

























































































































































































































































































































































































































































































Gordon Wilson put the envelope next to his breakfast plate, considering.  He’d 
received a similar one, five years ago shortly after his 50th birthday, but had let the letter it 
contained moulder away under a steadily-increasing pile of detritus consisting in the main of 
torn envelopes, shiny brochures advertising the latest supermarket offers and notifications 
telling him he had won a few thousands of dollars, if only he would complete and return the 
enclosed form.  Eventually the pile, including that particular letter, had found its way into the 
garbage bin.  The package that had arrived a couple of weeks later, which at the time he 
recalled had been referred to in the letter, eventually found the same fate with the same 
company.  
But … this time he was five years older and perhaps that was why, he thought, he was 
taking more notice.  The envelope bore the logo of the Australian Government. The letter was 
from the National Bowel Cancer Screening Program.  They were inviting people turning 50, 
55 and 65 years of age to screen for bowel cancer, and to that end he would shortly receive a 
faecal occult blood test kit.  The test was designed to detect tiny amounts of blood in the 
faeces, detection of which might be a sign of abnormality or bowel cancer. Gordon 
considered further.  He felt well, a few twinges when he got out of bed in the morning, but 
that was about it.  He didn’t know very much about bowel cancer but the kit was free.  He 















































































































































































































































































































Relationship of HBM and TRA/TPB Constructs to FOBT Screening Behaviour
&RQVWUXFW 1XPEHURIVWXGLHV 5HODWLRQ
  3UHGLFWHG 2SSRVLWHRISUHGLFWHG
1R
UHODWLRQ
3HUFHLYHGEHQHILWV    
3HUFHLYHGEDUULHUV    
3HUFHLYHGVXVFHSWLELOLW\    
3HUFHLYHGVHYHULW\    
$WWLWXGHV    
6RFLDOQRUPV    
3HUFHLYHGEHKDYLRXUDO
FRQWURO






























































































































































































































































































































































































































































































301 full-text articles 
assessed for eligibility 144 full-text articles 
excluded, with reasons
157 eligible for 
inclusion
114 excluded following 
decision to include RCTs 
only









































































































































































 Invitation vs. usual care.  















































































Invitation by personal contact vs. direct mailing of FOBT kit.










































































































































































































































































































































































































































































































































































































































Efficacy of Interventions to Increase FOBT Screening


























































































































































































































L WKDWZHKDYHPHWWKHFULWHULDIRUDXWKRUVKLSVHWRXWLQWKHAustralian Code for the Responsible Conduct of Research
LL WKDWWKHUHDUHQRRWKHUDXWKRUVDFFRUGLQJWRWKHVHFULWHULDDQG
LLL WKDWWKHGDWDRQZKLFKWKHVHILQGLQJVDUHEDVHGDUHVWRUHGDVVHWRXWEHORZ

























































































































































































































































































Before we contacted you, had you ever heard of a screening test for colorectal cancer, 
where you are given a set of cards to take home and asked to smear a part of your 
stool on the cards on two separate occasions, and then return the cards to be tested 
for blood? This is called a Faecal Occult Blood Test, or FOBT.  This is the type of 










































































































































Many people find that they intend to complete the FOBT but then forget or ‘never get 
around to it’.  It has been found that if you form a definite plan of exactly when and 
where you will carry out an intended behaviour you are more likely to actually do so 
and less likely to forget or find that you don’t get around to doing it.  It would be 
useful for you to plan when, where and how you will complete the FOBT.  To help you 












 you will use to carry out the screening test and obtain your result 
from the Bowel Health Service.
It is easy to forget to do things unless we have a way to remind us.  Decide now how 
you can make it easier for you to remember—for example, by leaving the kit or this 
plan in a prominent location, or writing yourself a note.  Write below how you will 
remind yourself to use the kit on two separate occasions. 
,QFRQWUDVWIRUWKHVDPHLQVWUXFWLRQWKHFKHFNOLVWVWDWHG³Place a reminder in a 

















&RPPLWPHQWWRVFUHHQZDVPHDVXUHGLQ3KDVHE\DVNLQJ³Right now, how strongly 
committed are you to doing this test, where 1 is undecided and 5 is very committed?” 7KH
IROORZXSLQWHUYLHZPHDVXUHGFRPPLWPHQWWRVFUHHQDJDLQIRUWKRVHZKRKDGUHWXUQHGWKHLU
)2%7³Now that you have done this screening test once, do you think you’ll go on doing it 
every two years?”\HVQRDQVZHUDQG³Right now, how strongly committed are you to doing 
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Commitment to screen and maintain screening. 
$WEDVHOLQHWKHPDMRULW\RISHRSOHQ ZHUHFRPPLWWHGRUYHU\
FRPPLWWHGWRGRLQJWKHWHVW0 6' PHGLDQ DQGWKHUHZHUHQRJURXS
GLIIHUHQFHV7DEOH7KRVHZKRUHWXUQHGDQ)2%7ZHUHDVNHGWKHLUOHYHORIFRPPLWPHQW
WRPDLQWDLQVFUHHQLQJDQGMXVWRYHUKDOIQ ZHUH³YHU\FRPPLWWHG´WR












Study 1 Mean Self Efficacy Scores Pre- and Post-Intervention, Overall and by Return/Non 
Return of FOBTs
 0 6' GI W
6(VFRUHQRQUHWXUQHUVIXOOVDPSOH 7LPH    
7LPH  
6(VFRUHUHWXUQHUVIXOOVDPSOH 7LPH    
7LPH  
/RZEDVHOLQH6(VFRUHQRQUHWXUQHUV 7LPH    
7LPH  
/RZEDVHOLQH6(VFRUHUHWXUQHUV 7LPH    
7LPH  
+LJKEDVHOLQH6(VFRUHQRQUHWXUQHUV 7LPH    
7LPH  
+LJKEDVHOLQH6(VFRUHUHWXUQHUV 7LPH    7LPH  
** p<.01. ***p<.001
7DEOH6WXG\0HDQ&RPPLWPHQWWR6FUHHQ3UHDQG3RVW,QWHUYHQWLRQ




































Study 1 FOBT Returners’ Commitment to Screen Pre- and Post-Intervention, Overall and by 
SE Level at Baseline
















Effect of self efficacy and commitment to screen on use of FOBT.
/RJLVWLFUHJUHVVLRQZDVXVHGWRDVVHVVWKHLQGHSHQGHQWDQGMRLQWHIIHFWVRIEDVHOLQH6(
DQGEDVHOLQHFRPPLWPHQWWRVFUHHQRQUHWXUQRI)2%76(DORQHPDGHDVWDWLVWLFDOO\


























































































































































































































































































































































































































































































1DPHRIFRQWULEXWRU 6LJQDWXUH 'DWH &RQWULEXWLRQ
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Results of Single Group Confirmatory Factor Analysis, Compared to U.S. Results 
0RGHO Q Ȥ GI S $,& &), 506($ &,
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Model 3 Factor Loadings (Standardised) 
















































































































































































































































































































































































YLL WKDWZHKDYHPHWWKHFULWHULDIRUDXWKRUVKLSVHWRXWLQWKHAustralian Code for the Responsible Conduct of Research
YLLL WKDWWKHUHDUHQRRWKHUDXWKRUVDFFRUGLQJWRWKHVHFULWHULDDQG
L[ WKDWWKHGDWDRQZKLFKWKHVHILQGLQJVDUHEDVHGDUHVWRUHGDVVHWRXWEHORZ














































































































































































































































































































































































 6DOLHQFHDQGFRKHUHQFH  &RORUHFWDOFDQFHUVFUHHQLQJPDNHVVHQVHWRPH
   +DYLQJFRORUHFWDOFDQFHUVFUHHQLQJLVDQLPSRUWDQWWKLQJIRUPHWRGRE
   +DYLQJFRORUHFWDOFDQFHUVFUHHQLQJFDQKHOSWRSURWHFWP\KHDOWK
   ,ZLOOEHMXVWDVKHDOWK\LI,DYRLGKDYLQJFRORUHFWDOFDQFHUVFUHHQLQJF
 6RFLDOLQIOXHQFH  ,ZDQWWRGRZKDWPHPEHUVRIP\LPPHGLDWHIDPLO\WKLQN,VKRXOGGRDERXWFRORUHFWDO
FDQFHUVFUHHQLQJ
   0HPEHUVRIP\LPPHGLDWHIDPLO\WKLQN,VKRXOGKDYHFRORUHFWDOFDQFHUVFUHHQLQJE
   0\GRFWRURUKHDOWKSURIHVVLRQDOWKLQNV,VKRXOGKDYHFRORUHFWDOFDQFHUVFUHHQLQJE
   ,ZDQWWRGRZKDWP\GRFWRURUKHDOWKSURIHVVLRQDOWKLQNV,VKRXOGGRDERXWFRORUHFWDO
FDQFHUVFUHHQLQJ
 &DQFHUZRUULHV  ,DPDIUDLGRIKDYLQJDQDEQRUPDOFRORUHFWDOFDQFHUVFUHHQLQJWHVWUHVXOW
   ,DPZRUULHGWKDWFRORUHFWDOFDQFHUVFUHHQLQJZLOOVKRZWKDW,KDYHFRORUHFWDOFDQFHU
RUSRO\SV
 3HUFHLYHGVXVFHSWLELOLW\  7KHFKDQFHWKDW,PLJKWGHYHORSFRORUHFWDOFDQFHULVKLJK







   ,WLVYHU\OLNHO\WKDW,ZLOOGHYHORSFRORUHFWDOFDQFHURUSRO\SV
   7KHFKDQFHVWKDW,ZLOOGHYHORSFRORUHFWDOSRO\SVDUHKLJKE
 5HVSRQVHHIILFDF\  :KHQFRORUHFWDOSRO\SVDUHIRXQGDQGUHPRYHGFRORUHFWDOFDQFHUFDQEHSUHYHQWHGE
   :KHQFRORUHFWDOFDQFHULVIRXQGHDUO\LWFDQEHFXUHG
6HOIHIILFDF\   ,WKLQNWKDWGRLQJWKHWHVWZRXOGEHHDV\IRUPHE
   )LQGLQJWLPHWRGRWKHWHVWZRXOGEHGLIILFXOWIRUPHF
   &RPSOHWLQJWKHWHVWFRUUHFWO\ZRXOGEHHDV\IRUPH
)HFDODYHUVLRQ  &ROOHFWLQJIHFHVIRUWKHSXUSRVHRIERZHOFDQFHUVFUHHQLQJLVXQK\JLHQLFF
   &ROOHFWLQJIHFHVIRUWKHSXUSRVHRIERZHOFDQFHUVFUHHQLQJLVGLVWDVWHIXOEF



































Creating a Library of Tailored Messages for the Preventive Health Model (PHM) Factor 






























>1DPH@you really don’t believe that colon cancer screening is effective. In 

















Relating Preventive Health Model (PHM) Factors to Precaution Adoption Process Model 

























Greg, you believe that colon cancer screening is effective.  You’re absolutely right.  
That’s why the Australian Cancer Council recommends yearly screening for people over 50 
who are of average risk. It’s an important step to take to protect your health for the future, 
and could save your life. 
However, you’re not sure whether you’re at risk for having or developing colon 
polyps or cancer.  Well, you are at risk.  Colon polyps are common in people over 50, and 
colon cancer is a common cancer in this age group.  You are 57, so your risk for these 
conditions is increasing as you get older. 
&KXQN7H[W<RXU,QIRUPDWLRQ3DUW
You think that screening would be a difficult thing to do, but it really isn’t.  The FOBT 
kit is designed to be easily used in the privacy of your home at your own convenience, where 
you can take all the time you need. 
You do think colon cancer screening makes a lot of sense.  You’re right, Greg.  People 
can have colon polyps or cancer and not know it.  Screening can find any problems early and 
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 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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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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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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+HDUGRI)2%7Q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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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Means and Standard Deviations on all PHM, Fecal Aversion, and Self-Efficacy Outcome 
Variables According to Condition 
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
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  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5HVSRQVH
HIILFDF\  < .001      
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Request and Return of Fecal Occult Blood Tests (FOBTs) by Intervention Group 













Ȥð P Q 
)2%7VUHTXHVWHG         





It was really in response to the information I had given, and, it wasn’t 
patronizing but it was really just confirming...Yes, I think that approach is beneficial.  
It drags you in; it’s like having a conversation.  >PDOHWDLORUHG:HE@
7KHIDFWWKDWWKHWDLORUHGLQIRUPDWLRQDGGUHVVHGDQLQGLYLGXDO¶VVSHFLILFUHVSRQVHVZDV
SRVLWLYHO\UHJDUGHG
I think it reinforced things for me...I’d made one comment that I perhaps 
agreed or disagreed, but this was actually telling me why it was different...So for me 







I sort of didn’t realize what I had said.  Well, I think probably I’ve thought 
about it since, and thought well that was a stupid statement to make...it was just a bit 
strange seeing things that I’d said.  >IHPDOHSDSHUWDLORUHGJURXS@
$FFHSWDELOLW\RIWKHZHEVLWH
7KHSUHVHQWDWLRQRIWKH:HEWRROZDVGHVFULEHGDVUHTXLULQJLPSURYHPHQW
I’d be looking for clear indication on the site that gave me very quickly, very 
clearly without a lot of words, what I’ve gotta >VLF@ look for and what I can do to find 
out.  It was a bit long and a bit wordy—trying to put too much information.  You can 
do more with pictures than you can do with words.  >PDOH:HEQRQWDLORUHGJURXS@
...it wasn’t very exciting.  It was very boring... there weren’t any pretty 
pictures, it was sort of, you know—very basic. >IHPDOH:HEQRQWDLORUHGJURXS@





It rose >VLF@ my awareness.  I’m now aware that that’s a test that I should be 
looking for.  And put it in the same bracket as prostate cancer, whereas it was not 
even on my radar.  >PDOHSDSHUWDLORUHGJURXS@
When I saw the graph and I saw prostrate >VLF@ cancer and I saw bowel cancer 
and they were almost identical, can’t remember the exact numbers, but they were 
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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objectives of this review are:
1. To assess the effectiveness of interventions designed to improve the uptake of an initial (ﬁrst-time) FOBT by those regarded to be at
average risk of colorectal cancer.
2. To assess the effectiveness of interventions undertaken to improve adherence to repeat (serial) FOBT screening by those regarded to
be at average risk of colorectal cancer.
The term “average risk” applies to persons without a predisposition to the disease, whose only risk factor is that their age is greater than
50 years.
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B A C K G R O U N D
Colorectal cancer (CRC) is one of the three most common can-
cers in Europe, North America, Northern Africa, Western Asia,
South Eastern Asia and Australia ( WHO 2003a) In the United
States, in 2003 it was predicted to account for 10% of all cancer-
related deaths (ACS 2003, quoted in Chorost 2004). In the Eu-
ropean Union, in 1995 CRC accounted for 13% of new cancer
cases (ACCP 2000). InAustralia, in 1990CRCwas responsible for
14% of cancer deaths (NHMRC 1999) and is the most frequently
occurring cancer for new cases (AIHW 2003). Most CRCs are be-
lieved to evolve from adenomatous polyps (pre-cancerous, visible
protrusions that can develop on the mucosal surface of the colon
or rectum), althoughmost polyps do not evolve into cancer. Bowel
cancer is rare in people under the age of 50, and the risk increases
with age. In Australia, there is currently a 1 in 17 lifetime risk for
males of being diagnosed with colorectal cancer by the age of 75
years and a 1 in 26 risk for females (AIHW 2003).
At the primary prevention level, it is believed that eating a healthy
diet and exercising regularly could prevent 66-75%of bowel cancer
cases (Anonymous 2002). Unfortunately, strategies to address such
risk factors as physical inactivity, overweight and consumption of
foods that are high in saturated fat and/or low in ﬁbre, require a
great deal of concerted, coordinated effort, extending to the global
level (WHO 2003a). Even so, It is not certain that individual risk
reduction through such lifestyle modiﬁcations would ensue, and
they may not be sufﬁciently effective as an approach to disease
control (Levin 2002). In addition, some predisposing factors for
colorectal cancer cannot be changed. They include older age, fam-
ily history of CRC, individual history of CRC or polyps, certain
hereditary conditions and inﬂammatory bowel disease (Gazelle
2000). However, the majority of CRCs are diagnosed in asymp-
tomatic people whose only risk factor is age, who therefore could
be considered as being at average risk (Barry 2002).
CRC is highly curable if it is diagnosed early, because it has a long
pre-clinical phase that allows detection by screening before it be-
comes surgically incurable (Chorost 2004). Data from South Aus-
tralia show that the 5-year survival rate is 88% for StageA (localised
disease) compared to only 7% for Stage D (distant metastases),
which equates with international experience (NHMRC 1999).
Screening is recommended for those of 50 years and older because
the incidence of CRC begins to rise between 40 and 50 years of
age. Screening guidelines vary with the method used-for fecal oc-
cult blood testing, screening is recommended at least biennially,
and preferably annually (ACCP 2000; Winawer 2003).
Fecal Occult Blood Testing (FOBT) is the most commonly used
screening modality in the United States (Ransohoff 2002) and has
been the focus of national bowel screening program pilots in Aus-
tralia and the UK (AIHW 2003; UK CRC Pilot 2003). FOBT
screening can be regarded as “a sequence of risk reﬁnement leading
to a ﬁnal decision as to whether or not one should undertake the
deﬁnitive diagnostic test” (NHMRC 1999). FOBT detects blood
in the stool and is useful because cancers and adenomatous polyps
bleed more than normal (it has been estimated that around two
thirds of colon cancers bleed in the course of a week) (Chorost
2004). To date, two types of FOBT are available - guaiac tests (re-
hydrated and non-rehydrated) and immunochemical tests. Gua-
iac tests are based upon the psuedoperoxidase activity of haem.
Immunochemical tests utilise antibodies against human haemo-
globin. A positive result indicates the need for a diagnostic exam-
ination such as a sigmoidoscopy or colonoscopy.
However, universal consensus does not exist for the choice of
FOBT as a screening programme tool (Autier 2002). Concerns
exist about the sensitivity (the effectiveness of a test in detecting
a cancer in those who have the disease) and speciﬁcity (the ex-
tent to which a test gives negative results in those that are free
of the disease) of FOBT screening. Reported sensitivity for the
detection of cancer ranges from around 40% to 90%, but only
from 10% to 25% for the detection of polyps. The speciﬁcity of
FOBT ranges from around 90% to 98%, depending on the type of
test, (whether rehydrated or non-rehydrated) (Gazelle 2000). This
means that up to 10% of patients who undergo FOBT screening
will have a false-positive result. This propensity need not neces-
sarily be regarded as a negative; it has been suggested that the high
incidence of false-positive results contribute towards the effective-
ness of FOBTscreening (Gazelle 2000). Indeed, Australian clinical
practice guidelines stress that individuals should be told that it is
not a diagnostic test, but a “selection process for those who should
undergo colonoscopy” (NHMRC 1999). A problem arising from
this approach is that those individuals with a false positive result
may undergo needless anxiety, as well as the discomfort, cost and
risk of colonoscopy.
Despite these limitations, FOBT screening is the safest and least
expensive of the currently available screening tests (Chorost 2004;
Gazelle 2000). The results of randomised trials of FOBT screening
have indicated a reduction in mortality of 23% in the population
that were actually screened, as well as a favourable shift in the stage
distribution of colorectal cancers in the screening groups (Towler
1998). FOBT trials suggest that, after an interval of about 10 years,
there could be a reduction of up to 20% in CRC mortality from
biennial screening and even more from annual screening (WHO
2003b). However, these projections depend on high uptake and
adherence to regular screening.
Unfortunately, initial uptake and continuing adherence to annual
FOBT screening is low (Vernon 1997). A national survey under-
taken in the United States in 2001 found that only 23.5% of those
over 50 years had a FOBTwithin one year (Seeff 2003). A popula-
tion uptake of less than 20%was achieved in Japan in 1998, and in
Germany FOBT compliance, after a screening programme of 25
years, was only 20% for men and 30% for women (Baker 2004).
Screening uptake tends to be even lower in minority groups; a sur-
vey conducted in California in 2001 found that Hispanics, Asians,
and Native Hawaiians are less likely to be screened than whites
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or African Americans, even after adjusting for sociodemographic
factors (Ponce 2003). The same survey also found that women as a
population group were screened less frequently thanmen. A recent
review examining factors affecting the utilisation of CRC screen-
ing tests (not just FOBT) in the United States concluded that fear
of ﬁnding cancer and the belief that cancer is fatal results in low ad-
herence, while a positive attitude toward screening and physician
recommendation results in high adherence (Subramanian 2004).
Other factors reported to be associated with reduced utilisation
of FOBT include fear of pain, embarrassment, distaste, lack of
perceived need, fear of the results, fatalism (belief that nothing can
be done) and feeling well (Baker 2004; Rex 2002).
Intervention strategies can employ a number of “social cognitive”
models which have proven effective in describing individual mo-
tivation to perform a variety of health behaviours by identifying
a range of attitudinal predictors. These include the Health Belief
Model (Rosenstock 1974), ProtectionMotivation Theory (Rogers
1975), and the Theory of Planned Behaviour (Ajzen 1991). These
models can successfully map variables that describe individual dif-
ferences in the intention to perform a behaviour. However, the
relationship between behavioural intention and actual behaviour
is less than perfect (Sheppard 1988).
There is a clear need for a deeper understanding of what are ef-
fective strategies to promote increased uptake of FOBT screen-
ing, bearing in mind that one of the most common reasons given
for not having a recent colorectal screening test is the absence of
any current health problems (Ponce 2003). Differences in FOBT
uptake may also exist between gender, ethnic and socio-economic
groups. As an additional complication, those who choose to have
an initial FOBT may not necessarily choose to adhere to repeat
screenings (Craven 2001). Therefore, approaches to promote long-
term CRC screening change may differ from those required to
promote the uptake of screening.
O B J E C T I V E S
The objectives of this review are:
1. To assess the effectiveness of interventions designed to improve
the uptake of an initial (ﬁrst-time) FOBT by those regarded to be
at average risk of colorectal cancer.
2. To assess the effectiveness of interventions undertaken to im-
prove adherence to repeat (serial) FOBT screening by those re-
garded to be at average risk of colorectal cancer.
The term “average risk” applies to personswithout a predisposition
to the disease, whose only risk factor is that their age is greater
than 50 years.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All prospective studies evaluating the effectiveness of an interven-
tion designed to increase FOBT screening use are eligible for inclu-
sion if they include a control group. Thus, studies can encompass
randomised controlled trials (RCTs), cluster RCTs, quasi-RCTs
(for example, using pseudo randomisation such as alternation or
date of birth), and controlled trials (non-randomised cohorts, pre-
post studies with concurrent controls and one group pre/post in-
tervention). The control group comparison can be no intervention
or another type of intervention. Studies can be in any language,
although inclusion of non-English language studies will depend
upon resources available for translation.
Studies that seek only to measure informed uptake or the psycho-
logical impact of screening, or intention to undertake screening,
will be excluded. However, where these studies include uptake of
screening as a secondary outcome they will be included. Studies
employing compulsory FOBT screening (for example in prisons
or mental institutions) will be excluded. Review articles will be
retrieved and examined for possible relevant studies.
Types of participants
All those individuals or groups eligible to participate in a voluntary
FOBT screening programme as deﬁned by the entry criteria for
that programme. Participants should be at average risk of colorectal
cancer.
Types of interventions
Interventions can be any individual, group or population strategies
directed towards the public or health professionals or both, that
aim to increase the uptake of FOBT screening. Certain speciﬁc in-
terventions will not be included as they are the subject of separate
Cochrane protocols or reviews. These are informed decision mak-
ing (Broclain 2004), counselling (Doust 2004), and personalised
risk-factor assessment (Edwards 2004). Screening can be universal
(when the entire population is the target) or opportunistic (when
physicians propose or patients ask for a screening test in ordinary
consultations).
All other interventions will be classiﬁed in the same manner as
that employed by (Jepson 2000) in the preparation of their sys-
tematic review of interventions for increasing screening uptake.
Speciﬁcally, these will be:
Interventions aimed at individuals
Invitations
Invitations to people eligible for screening (either ﬁrst round or
subsequent round). Does not include people who are overdue for
screening. Includes ﬁxed or open appointments, letters, telephone
calls, verbal recommendations, prompts and follow-up letters.
Reminders
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Reminders to people who are overdue for screening and have not
responded to the ﬁrst round of screening. Includes ﬁxed or open
appointments, letters, telephone calls, verbal recommendations,
prompts and follow-up letters.
Education
Educational interventions aiming to increase knowledge of the
screening programme or the disease being screened for. Does not
contain a counselling component. Includes printed educational
materials, audio visual materials, group and individual teaching,
and home visits.
Procedures
Interventions to increase screeninguptake bymaking the screening
procedure easier or more acceptable to individuals undergoing
screening. Includes varying diets, method of specimen collection,
method of specimen delivery for analysis, opportunistic testing.
Economic
Removal of ﬁnancial barriers or economic incentives. Includes
reduced or free screening tests, transport costs, free postage for
returning tests and ’rewards’ for completion of a screening test.
Community interventions
Interventions aimed at whole communities. Often involve mul-
tiple interventions. Includes mass media campaigns, community
participation, workplace programmes.
Interventions aimed at physicians or other healthcare workers
Reminders
Reminders to physicians to prompt or encourage individuals to
undergo screening. Includes chart reminders, forms, computer-
generated reminders and lists of overdue patients.
Education
Continuing medical education. Includes seminars, workshops and
meetings.
Ofﬁce systems
Assistance to physicians from facilitators in design and implemen-
tation of ofﬁce routines and tools.
Audit and feedback
Audit and feedback to physicians on their performance, and some-
times that of their peers.
Studies will be subject to sub-group analysis based on the above
list of interventions. Only studies with one or more of these inter-
ventions will be included in the review.
Types of outcome measures
• Initial screening uptake or non-uptake of FOBT as
recorded by health service records or self report
• Adherence to a ﬁrst repeat FOBT screening following no
indication for further investigation at initial screening, as
recorded by health service records or self report.
• Continuous adherence to long term programs which
include a number of annual or biennial screening rounds, as
recorded by health service records or self report.
The psychological impact of FOBT screening will not constitute
a formal outcome measure as this topic is the subject of a separate
protocol (Doust 2004). However, where this outcome is reported
upon it will be recorded.
Search methods for identiﬁcation of studies
Relevant studies published after 1971, the year it was demon-
strated that detection of occult rectal bleeding by means of a gua-
iac-based chemical slide test could uncover subclinical bowel dis-
ease (Greegor 1971) will be sought. Conference abstracts (either
published or presented at scientiﬁc meetings) will also be searched.
Leading researchers in the ﬁeld will be contacted and asked if they
are aware of any relevant articles or studies that should be included
in the review.
PubMed, EMBASE, Cancerlit, ISI Current Contents, ISIWebOf
Science, PsycInfo, Cochrane database of systematic reviews, and
ISI Proceedings will be searched for relevant studies, as well as
the Specialised Trials Register of the Cochrane Colorectal Cancer
Group. Additionally, bibliographies of related protocols and re-
views will be examined for relevant studies. The Pubmed search
strategy will be as follows:
(colorectal neoplasms/ OR colorectal cancer OR colon cancer OR
CRC OR bowel cancer OR colorectal carcinoma OR colorectal
neoplasia) combined with
(occult blood/ OR fobt OR fecal occult blood test* OR faecal
occult blood test*) AND
(mass screening/ OR screening OR surveillance OR screening be-
havio* OR population screening OR screening program*) com-
bined with
(intervention* OR letter OR mail* OR phone OR telephone OR
reminder system* OR videotape recording* OR questionnaire*
OR strateg* OR alert*ORhotline OR community ORmedia OR
education* OR campaign*) combined with
(uptakeOR complian* ORparticip*OR adher*ORpatient-com-
pliance/ OR patient acceptance of health care/ OR utilisation OR
utilization OR attend* OR incidence OR prevalence OR preve-
lence OR satisfaction OR cooperat* OR behavio*)
Data collection and analysis
The review will be undertaken by four reviewers (I Flight, C Wil-
son, L Grifﬁths, R Myers), one of whom (RM) has conducted
cancer prevention, control, and population science research for
over 18 years. The search strategy previously described will be used
by LG to obtain titles and abstracts of studies that are potentially
relevant to the review. She will discard studies that are clearly in-
eligible but will aim to be overly inclusive rather than risk losing
relevant studies. Where there is insufﬁcient information to deter-
mine relevance, full paper copies of articles will be obtained (LG)
and examined. A random sample (5%) of included and excluded
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papers will be checked by IF. Full copies of relevant papers will be
obtained (LG).
Complete copies of papers will be independently screened by IF
and CW, who will assess whether the studies meet the inclusion
criteria, with disagreements to be resolved by discussion with the
fourth reviewer (RM).
Data extraction will be performed by IF and the completed data
extraction forms will be double-checked against the original paper
by CW. The quality of all studies which are deemed eligible for the
review will then be independently assessed by IF and CW against
quality criteria. Any discrepancies will be resolved by discussion
between the reviewers.Methodological and quality assessment will
be modelled upon the tool developed by the Canadian Effective
Public Health Practice Project (Anonymous 2004), because it pro-
vides the capability to assess other types of trial designs in addition
to randomised or quasi-randomised controlled trials. Content and
construct validity for this tool have been established (as reported
by Ellis 2003), and it has been recommended as being suitable
for use in a systematic review (Deeks 2003). Brieﬂy, the following
questions will be addressed:
• Are the individuals selected to participate in the study likely
to be representative of the target population?
• Is assignment to intervention groups random?
• If described as random, was assignment truly random
(allocation concealment)?
• Are those assessing outcomes blind to the intervention
allocation?
• Are the control and intervention groups comparable at
entry?
• Were the data collection tools shown to be valid and
reliable?
• Is relatively complete follow-up achieved?
• Are the outcomes of those who withdrew described and
included in the analysis?
• Is there adequate outcome measurement (veriﬁable data
versus self-report)?
• Is the analysis appropriate (eg cluster randomisation taken
into account in the analysis)?
For each included trial, information will be collected regarding
the location of the study, methods of the study (as per the quality
assessment criteria), the participants, the nature of the interven-
tions, and data relating to the outcomes speciﬁed above. If an in-
tervention is stated by the researchers as being based on a partic-
ular behavioural model, this information will be recorded. Where
possible, missing data will be sought from the authors.
Statistical analyses will be performed for controlled trials described
as being randomised (using relative risks (RR) as the measure of
effect for each outcome) and for non-randomised controlled trials
(using rate difference as the measure of effect for each outcome).
Initial, ﬁrst repeat and continuous adherence to screeningwill each
be treated as a dichotomous outcome for individuals. Where there
are sufﬁcient data, a summary statistic for each outcome will be
calculated using a Random Effects model. Heterogeneity in the
data will be noted and cautiously explored using previously iden-
tiﬁed characteristics of the study, particularly assessments of qual-
ity. Detailed sensitivity analyses will be undertaken to examine the
stability of the results in relation to a number of factors including
study quality, source of the data (published or unpublished) and
publication bias (using a funnel plot-based method, Duval 2000)
. FOBT uptake as measured by medical records and self-reported
uptake will also be subjected to sensitivity analysis. (Whereas some
researchers have found that self-reports of colon cancer screening
can be reliably used as end points for intervention trials when
carefully phrased questions are asked (Baier 2000), others have
found that that the speciﬁcity of self-reports (those who correctly
reported having had the test and who could be shown to have
actually had the test as indicated by medical records) is relatively
low (Gordon 1993).
Subgroup analysis will also be considered on gender, ethnicity, and
socio-economic status.
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1. Introduction 
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and second 
in females; throughout the world over 1.2 million new CRC cases and 608,7000 deaths are 
estimated to have occurred in 2008 (Jemal et al., 2011). The only developed country to have 
demonstrated a significantly decreasing incidence in both males and females is the United 
States, and this is largely due to the early detection and removal of pre-cancerous lesions 
through CRC screening (Jemal et al., 2011). Thus, an understanding of the variables that 
encourage people to participate in CRC screening is important because early detection and 
treatment of precancerous lesions and adenomas results in a significantly higher survival 
rate than if treatment is delayed until physical symptoms of the condition are apparent. 
Population screening using a Faecal Occult Blood Test (FOBT) can facilitate the detection of 
CRC at its early stages. FOBT is the collective term for a guiaic FOBT (gFOBT) or a faecal 
immunochemical test (FIT). Both are home-based tests which, although differing in the 
technology utilised, involve a stool sample being sent to a laboratory to be analysed for 
occult blood, ideally followed by colonoscopy for those with a positive result. The cost 
effectiveness of FOBTs for the screening of CRC, measured as Quality Adjusted Life Years 
gained, is comparable to other screening procedures (Frazier et al., 2000) and more cost-
effective than treatment after physical symptoms are evident (Fisher et al., 2006). 
Randomised clinical trials have shown that both biennial and annual screening using FOBT 
screening reduces CRC incidence (Mandel et al., 2000) and mortality (Hardcastle et al., 1996; 
Kronborg et al., 2004; Mandel et al., 1993), and a systematic review concluded that FOBT 
screening is likely to avoid 1 in 6 colorectal cancer deaths (Hewitson et al., 2007). 
Effectiveness, however, depends upon yield and is critically dependent upon participation 
rates, which for population-based screening programs have been low, often despite high 
levels of intention to participate. For example, in Australia the National Bowel Cancer 
Screening Program, which provides people turning 50, 55 and 60 years with a free FOBT, 
had a participation rate in 2008 of 41% of the eligible population (AIHW, 2010). In England, 
the second round (2003–2005) of the pilot bowel cancer screening program had a 
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significantly lower uptake than in the first round (52% vs 58%) (Weller et al., 2006) and 
reported participation rates in 2008 in other countries with an established or pilot 
population FOBT screening program ranged mostly from a moderate 45–50% (Italy and 
Denmark, respectively) to a low 16–18% (Korean Republic and Japan, respectively) level 
(International Cancer Screening Network, 2008). Understanding motivators to intention to 
participate and motivators to test completion are critical issues that need to be addressed.  
The central question in research within health psychology is identifying and understanding 
the range of influences that prompt an individual to take up healthy behaviours or reject 
patterns of behaviour which compromise their health. Many social cognitive health 
behaviour models include a measure of intention to behave in a specific way as a precursor 
to action (e.g., Theory of Planned Behaviour; (Ajzen, 1985). Stage models focus specifically 
on the importance of addressing intention as a core component of public health 
interventions. For example, the Transtheoretical, or Stages of Change, Model (Prochaska, 
2008; Prochaska et al., 1988) suggests that people can be characterised in terms of their 
readiness to make a change. Stages include precontemplation (benefits of lifestyle change 
are not being considered), contemplation (starting to consider change but not yet begun to 
act on this intention), preparation (ready to change the behaviour and preparing to act), 
action (making the initial steps toward behaviour change), and maintenance of the 
behaviour over time; with both contemplation and preparation measuring aspects of 
intention. 
One of the most difficult questions for researchers examining screening participation has 
been the question of how to move people along these stages to the performance of the actual 
behaviour and, ideally, maintenance of the behaviour. A range of social cognitive models of 
health behaviour have proven effective in describing individual motivation to perform a 
variety of health behaviours, including screening, by identifying a range of attitudinal 
predictors (Conner & Norman, 2005). Each of these deliberative models can successfully 
map variables that describe individual differences in the intention to perform a behaviour. 
However, the relationship between behavioural intention and actual behaviour is less than 
perfect; it has been shown that around 50% of people with positive intentions to engage in 
health behaviours successfully translate those intentions into action (Sheeran, 2002), and a 
medium-to-large change in intention leads to only a small-to-medium change in behaviour 
(Webb & Sheeran, 2006). 
This ‘gap’, the difference between an individual’s commitment to act and initiation of the 
necessary processes to actually carry out the behaviour, needs to be bridged—in other 
words, research that influences ‘intention to try’ (Bagozzi & Warshaw, 1990) needs to also 
identify cues that will enable people to link to the means for achieving the intended 
behaviour. Some health behaviour models incorporate a stimulus to action in their 
operationalisations in an attempt to capture this intervening, or additive, influence that 
prompts individuals to actually implement behaviour. For example, Becker and colleagues 
(1977) incorporated ‘cues to action’ as additional, independent predictors of health 
behaviour, over and above attitudinal variables. Although incorporated in the earliest 
descriptions of the Health Belief Model, a cue to action, or strategy to initiate “readiness”, is 
a variable that has received limited attention in the empirical literature. Nevertheless, 
research does suggest that certain acts may serve to stimulate health behaviour including 
physician advice, advertising campaigns, and postcard reminders (Sheeran & Orbell, 2000). 
Research originating outside the health area has examined the notion of volitional control 
and how it might be used to explain the problematic nature of the relationship between 
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behavioural intention and behaviour (Gollwitzer, 1993). This model suggests that 
individuals achieve volitional control of their intention to act by the development of 
implementation intentions; the plans made to achieve a specific behavioural target (e.g., a 
statement describing when, where and how a specific behaviour will be carried out). These 
plans serve to provide the cue to action identified by the Health Belief Model but go beyond 
this by providing the plan for goal achievement.  
Recent empirical work suggests that the approach of providing cues to action in the form of 
a specific implementation intention improves prediction of behaviour over and above the 
intention to act alone. Thus, Milne, Orbell and Sheeran (2002) reported improved exercise 
participation; Sheeran and Orbell (2000) reported beneficial effects on the uptake of cervical 
cancer screening; Verplanken and Faes (1999) described improved dietary regimens; and 
Orbell et al. (1997) cited improved rates of breast self-examination.  
A study examining uptake in the National Health Service Breast Screening Program 
(NHSBSP) in the UK (Rutter et al., 2006) has highlighted the importance of providing 
guidance on how to plan for a behaviour in order to ensure that people move from intention 
to actual behaviour (i.e., from the preparation to the action stage of the Transtheoretical 
Model, TTM). In this study, women invited to screen for breast cancer were asked to make 
specific plans for attending. The plans consisted of organising their travel, arranging to take 
time off work if necessary and changing the appointment if it was inconvenient. The results 
indicated that when women produced a written plan, actual rate of compliance with the 
screening appointment was 15% greater than in the control condition (no intervention) and 
7% greater than women who failed to write down a plan although instructed to do so. 
Moreover, the influence from the production of cues to action in the form of a written plan 
was greatest for those who initially had a high intention to comply but a weak sense of 
control over making the necessary arrangements to put that intention into effect. This 
research suggests that uptake of FOBT might be significantly improved by providing a cue 
to action that seeks to stimulate people to do more than simply express their intention to 
screen. An effective informational intervention that results in the development of 
implementation intentions in the form of a plan describing the when, where, and how of 
faecal occult blood testing, and which enables the individual to deal with their own personal 
and environmental constraints, should provide those with the intention to act the further 
resources necessary for achieving their goal. 
One possible mechanism for explaining the effectiveness in previous studies of asking 
participants to form implementation intentions is that doing so forces people to think 
through the steps necessary for actually completing the screening. This ‘thinking through’, 
in turn, may serve to raise people’s confidence about their ability to successfully carry out 
the screening behaviour. Confidence in one’s own capacity to act is known in the literature 
as ‘self efficacy’ and is widely reported as predicting health behaviour participation 
(Schwarzer & Fuchs, 1995). People’s feelings of self efficacy are likely to be a particular 
consideration in using the FOBT because the test is performed by the individual and not 
administered, like mammography or Pap smear, by a health care professional. Previous 
studies looking at consumer-initiated screening behaviours have shown that feelings of 
confidence in one’s ability to correctly perform the behaviour bear a strong relationship to 
people’s performance of these behaviours. This includes performance of breast self-
examination (Luszczynska, 2004), testicular self-examination (Lechner et al., 2002), and 
FOBT (DeVellis et al., 1990).  
 




This study was designed to investigate the effect of the formulation of implementation 
intentions upon people’s participation in screening using FOBT. We chose to examine 
uptake of FOBT rather than colonoscopy because, in comparison to the United States, usual 
CRC screening practice in Australia is by FOBT followed by colonoscopy for those with a 
positive result—in other words, colonoscopy is regarded as a diagnostic test rather than a 
screening test.  
An additional aim was to monitor the impact upon participation of differing levels of 
directedness in formulating these intentions and to determine the impact of self efficacy and 
prior levels of generalised intention upon both implementation intention formation and 
participation.  
Consistent with prior research, it was anticipated that the formulation of implementation 
intentions (regardless of level of directedness) would increase participation in FOBT over 
levels of participation in the control group. Furthermore, previous work in the area of 
preventive health behaviour suggests that people’s feelings of self efficacy, or confidence to 
use the test (the terms ‘self efficacy’ [SE] and ‘confidence’ will hereinafter be used 
interchangeably) can be increased in response to appropriate cues to action, and it was 
anticipated that the provision of directions for the formulation of implementation intentions 
would increase people’s feelings of self efficacy. It was further hypothesised that those who 
were already strongly intending to use an FOBT were expected to differ in implementation 
intention formation and participation from those whose intentions to test were initially 
weaker. 
We conducted two randomised controlled trials to test these hypotheses. Study 1 was a trial 
conducted amongst a group of eligible, randomly selected males and females who were 
approached and agreed to participate in the trial. Study 2 was also a randomised controlled 
trial to examine the generalisability of results to population settings and which differed 
from Study 1 in that prior commitment to trial participation was not obtained and eligibility 
was unknown.  
3. Study 1 
3.1 Methods 
3.1.1 Study design 
The study was a parallel, randomised, controlled trial, stratified by sex, comparing return of 
FOBT between three intervention groups and one control group. People in the intervention 
groups received an FOBT of the immunochemical type (FIT) in the mail together with 
instructions on how to construct a (1) participant-determined and retained plan, (2) 
participant-determined and shared plan, or (3) researcher-directed and shared plan. The 
control group received the FOBT only.  
3.1.2 Sample size and selection 
Previous studies of implementation intentions have demonstrated that the effect of their 
formation upon behaviour is medium to large (Gollwitzer & Sheeran, 2006). To achieve 
statistical power of .80 to detect a medium-sized effect (allowing for the possibility of self 
efficacy and generalised intention as co-variants) and an alpha of 0.05, we aimed to recruit a 
minimum of 80 participants in each of the four groups described above. Accordingly, 
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allowing for non-contactability by telephone, a subsequent rejection rate of 30% and 
ineligibility, we needed to recruit at least 1600 participants to achieve a final sample size of 
320 (160 men and 160 women). 
A random sample of 6000 (3000 males, 3000 females) potential invitees aged between 50 and 
76 years and residing in southern urban Adelaide, South Australia, was provided by the 
Australian Electoral Commission (AEC). The Australian Government was conducting a pilot 
National Bowel Cancer Screening Program (NBCSP) at the same time (2004) so individuals 
with postcodes within the Federal screening program were deleted from the sample 
provided.  
Telephone contact numbers for the remaining sample were obtained by comparing the list 
against information contained in the electronic White Pages telephone directory. Those 
persons for whom telephone contact details were not indicated were excluded from the list, 
as were those whose address indicated that they resided in a hostel or nursing home; such 
individuals were unlikely to be in the position of deciding for themselves whether they 
should screen for CRC. The remaining sample was randomized separately by sex using a 
random number generator (Microsoft ® Office Excel 2003) and 400 (200 m; 200 f) names 
were assigned sequentially to one of 4 groups. In total 1642 names were allocated. 
3.1.3 Study conduct 
The trial proceeded through a number of phases, as described below and illustrated in Table 1. 
Phase 1: All potential participants were mailed an advance notification letter and 
accompanying information, to the effect that an attempt would be made to contact them by 
telephone to invite them to participate in a study on how best to encourage people to 
participate in screening for colorectal cancer. Potential participants were advised that they 
were ineligible to participate if they had ever participated in CRC screening or been 
diagnosed with CRC or polyps. This exclusion criterion was because in Australia such 
diagnoses normally follow a positive FOBT and subsequent colonoscopy, and we wanted to 
target those who had not displayed overt symptoms but were of average risk (that is, based 
solely on the fact that they were aged 50 years or more) of developing CRC. An opportunity 
was provided at this point for individuals to decline participation or to indicate that they 
were ineligible.  
Phase 2: One week after the advance notification letter, attempts were made (to a maximum 
of 3 occasions) to telephone individuals and recruit them to the study. A Computer Assisted 
Telephone Interview (CATI) format was used by trained interviewers to collect interview 
responses (Microsoft ® Office Access 2003). For those who were contactable and agreed to 
participate, informed consent was formally requested and recorded before commencement 
of the CATI. The recruiting interviewers were blinded to an individual’s group allocation 
until they reached that part of the CATI (after having determined eligibility) that, as part of 
obtaining informed consent, provided details of the particular intervention to which the 
participant had been assigned. To those that agreed to participate, the interviewer briefly 
described what an FOBT was and asked whether they had heard of it: “Before we contacted 
you, had you ever heard of a screening test for colorectal cancer, where you are given a set of cards to 
take home and asked to smear a part of your stool on the cards on two separate occasions, and then 
return the cards to be tested for blood? This is called a Faecal Occult Blood Test, or FOBT. This is the 
type of screening test we will be sending you”. Baseline measures were obtained: background 
demographics, level of commitment to using an FOBT, and confidence to use the kit.  
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Table 1. Study 1 interventions by phase and arm, with attrition rates 
Phase 3: The day following the recruitment interview, all participants were mailed a 
screening package which included an immunochemical FOBT. Accompanying the package, 
intervention groups also received an implementation plan to serve as a ‘cue to action’ to 
provide a strategy for goal achievement (completion and return of the FOBT). Two 
intervention groups received a participant-directed plan in the form of an ‘Aide’ that invited 
participants to think about, and write down, how they were going to deal with potential 
barriers to using the FOBT. Suggestions were made as to how these barriers could be 
addressed. Participants in one of these two groups were asked to retain their completed 
plan (‘Aide to retain’); the other group were sent two copies of the plan and requested to 
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return one copy of the completed plan to CSIRO (‘Aide to return’). The third intervention 
group received a plan in the form of a researcher-directed ‘Checklist’ (‘Checklist to return’) 
which directed participants to think about how they were going to deal with potential 
barriers. This group was also provided with two copies of the checklist and asked to return 
one completed checklist to CSIRO. Thus, those in the intervention groups were invited to 
formulate implementation plans at differing levels of directedness, and the researchers, 
through their requirement that two of the intervention groups return a completed plan, 
were able to verify that in fact a plan had been completed. The control group received a 
screening package without any accompanying plan. 
Phase 4: Receipt of completed FOBTs was recorded by the Bowel Health Service 
(Repatriation General Hospital, Bedford Park, South Australia) and participation data 
relayed to the researchers. People who did not return their test after six weeks were sent a 
reminder letter. Participation in screening was defined as receipt of kit within 6 weeks 
(before reminder) or after 6 weeks.  
Phase 5: Approximately 7 weeks following FOBT despatch, participants were contacted by 
telephone. Confidence to use the FOBT was again measured, as was (for those who had 
returned their FOBT) commitment to screen every two years in the future, following 
recommended screening guidelines. Additionally, participants’ reasons for screening or not 
screening were elicited, depending on whether a completed FOBT had been returned at the 
time of interview (data not included in these analyses).  
3.2 Materials 
3.2.1 Development of implementation plans 
Two versions of implementation plan were designed; one as an ‘aide’ and the other as a 
more prescriptive ‘checklist’. Each version was introduced to the participant with the words 
“Many people find that they intend to complete the FOBT but then forget or ‘never get around to it’. 
It has been found that if you form a definite plan of exactly when and where you will carry out an 
intended behaviour you are more likely to actually do so and less likely to forget or find that you don’t 
get around to doing it. It would be useful for you to plan when, where and how you will complete the 
FOBT. To help you do this, we would like you to use the attached sheets we have provided” (adapted 
from Milne et al., 2002). Both plans were designed to support confidence and addressed 
practical aspects of completing the test (reading the instructions; deciding the most 
convenient time to use the FOBT; deciding the most convenient location to use the FOBT; 
preparing for the test; using the FOBT; remembering to use the FOBT; sending the FOBT for 
analysis). Both versions commenced with the instruction: “Using this plan, decide when you 
will use the screening kit, where you will use the kit, and the procedure you will use to carry out the 
screening test and obtain your result from the Bowel Health Service”. They thereafter differed in 
their level of directedness in covering the practical aspects. For example, for ‘remembering 
to use the kit’ the aides contained the following instruction: “It is easy to forget to do things 
unless we have a way to remind us. Decide now how you can make it easier for you to remember—for 
example, by leaving the kit or this plan in a prominent location, or writing yourself a note. Write 
below how you will remind yourself to use the kit on two separate occasions”. In contrast, for the 
same instruction the checklist stated “Place a reminder in a prominent place so that you do not 
forget to use the kit” with two check boxes (1st sample done; 2nd sample done) to indicate that 
this instruction had been carried out. The complete documents are available from the first 
author on request.  
 
Colorectal Cancer – From Prevention to Patient Care 
 
74
3.2.2 Development of self efficacy scale 
Self efficacy was measured using 4 items derived from terms developed by Vernon et al. 
(1997) and our clinical experience of the challenges and impediments surrounding FOBT 
use. Participants were asked to rate their degree of confidence in surmounting the barriers 
described. The items were scored on a 5-point Likert scale ranging from strongly disagree (1) 
to strongly agree (5). The items were: “I feel confident that I would be able to carry out an 
FOBT”; “I feel confident that the test will not be overly distasteful or embarrassing”; I feel 
confident that I would be able to find time in the day to complete the test”; “I feel confident 
that I could complete the test correctly”. The scale had good internal consistency, with a 
Cronbach alpha coefficient of .86. 
3.2.3 Commitment to screen 
Commitment to screen was measured in Phase 2 by asking “Right now, how strongly 
committed are you to doing this test, where 1 is undecided and 5 is very committed?”. The follow-
up interview measured commitment to screen again (for those who had returned their 
FOBT): “Now that you have done this screening test once, do you think you’ll go on doing it every 
two years?” (yes/no answer) and “Right now, how strongly committed are you to doing this test 
again, where 1 is undecided and 5 is very committed?” 
3.2.4 Screening offer 
The screening package, or kit, included (a) a bowel cancer screening information pamphlet; 
(b) an immunochemical FOBT ((iFOBT also known as a faecal immunochemical test for 
haemoglobin [FIT], InSure™, Enterix Australia) that does not require dietary or drug 
restrictions; (c) a combined Participant Details and Consent Form confirming personal 
details, nominating a preferred doctor for follow-up, and consent to obtain clinical follow-
up reports if required; and (d) a reply-paid return envelope.  
3.3 Data analysis 
Random missing values on pre- and post self efficacy (SE) variables (17/2800, 0.61%) were 
imputed using the expectation maximisation method, so that as many observations as 
possible were available for computing self efficacy total scores. The scores were split at the 
median baseline SE score of 17; scores 16 were designated ‘low’ and scores 17 ‘high’ SE. 
Participation rates were viewed as ‘early’ or ‘late’ at a cut-off point of 6 weeks following 
despatch of FOBT, at which time a reminder was sent to non-responders. Chi-square 
analysis was conducted to assess FOBT awareness, FOBT participation and return of 
implementation plans between groups; Fishers exact test was utilised where cells contained 
<5. Paired samples t-tests and one-way ANOVAs compared score means for self efficacy 
and commitment to screen. A median split was not performed for commitment to screen as 
the majority of people had high intention to screen. Binary logistic regression was used to 
examine the ability of self efficacy and commitment to screen to predict return of FOBT, and 
Generalised linear models (GLM) were used to assess interactions between variables. All 
tests were conducted using a two-sided alpha level of 0.05.  
3.4 Results 
Recruitment and participation attrition rates are shown at Table 1. From a sampling frame of 
potential participants (3,000 men and 3,000 women), n=1642 were notified that they would 
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be contacted and invited to participate. Of n=994 able to be contacted and eligible, n=364 
individuals (36.6%) agreed to participate in the study. Subsequently n=14 were excluded 
from analysis because they didn’t receive an FOBT (n=3); had undergone screening since 
joining the study (n=4); reported symptoms that precluded them from using the FOBT 
(n=4), or were unable to participate due to barriers unrelated to the study (n=3). Baseline 





























Age, mean 61.1 60.5 61.2 61.7 NS 
Age group**     X2 (6)=2.236, 
p=.897 
Age 50–59 43 (48) 38 (48) 45 (49) 37 (41)  
Age 60–69 31 (34) 29 (37) 32 (35) 39 (43)  
Age 70–76 15 (17) 11 (14) 14 (15) 13 (14)  
Highest level of 
education 
    X2 (6)=5.894 
p=.435 





















Country of birth: 
Australia 
67 (74) 57 (72) 71 (78) 61 (68) X2 (3)=2.539, 
p=.468 
Never heard of FOBT 
prior to participation 
64 (71) 65 (82) 59 (65) 65 (72) X2 (3)=5.618 
p=.132 
*percentages have been rounded so may not be equivalent to 100% 
** n=3 missing values for age group 
n=2 missing values 
Table 2. Study 1 Participant demographic characteristics*  
At follow-up (post intervention and mailing of FOBT), n=13 participants declined or were 
unable to be interviewed and n=9 were unable to be contacted; follow-up data were 
therefore available for n=328/994 (33%) participants.  
At recruitment, the groups (n=350 participants) were balanced for gender, mean age, age 
group, level of education and Australian birth, and awareness of FOBT. The majority of 
participants had never heard of an FOBT before they were approached, i.e. they were in pre-
contemplation stage (Table 2). 
3.4.1 FOBT participation 
Completed FOBTs were returned by n=286/350 (81.7%) of eligible participants over a period 
of 15 weeks (mean = 3.12 weeks). Contrary to the hypothesis that formation of 
implementation plans would improve FOBT uptake, there was no significant difference 
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between the groups in FOBT participation or return within 6 weeks (i.e., before and after 
reminder) (Table 3).  
 






















Return of kits 
within 6 weeks  
67 (74) 61 (77) 62 (68) 66 (73) X2 (3)=.869, 
p=.833 
Plans returned*   62 66 X2 (1)=.367, 
p=.545 
*These numbers do not correspond with participants who returned FOBTs within 6 weeks 
Table 3. Study 1 return of kits and implementation plans by group 
3.4.2 Return of implementation plans 
Most participants who returned a completed FOBT and were also required to return a 
completed implementation plan did so. There was no significant difference in rate of return 
between aide and checklist (Table 3), suggesting that differing levels of directedness had no 
impact on whether the plans were completed. There were no cases of a plan being returned 
without an accompanying completed kit.  
3.4.3 Self Efficacy (SE) 
A mixed between-within subjects analysis of variance was conducted to assess the impact of 
the different interventions on follow-up SE scores. There was no significant interaction 
between intervention group and time [F(3, 324) = .874, p=.455]. There was a substantial main 
effect for time [F(1,324) = 46.424, p=<.005), ǈ2 = .125] with groups showing an increase in 
self efficacy (Time 1, M = 17.45, SD = 1.95; Time 2, M = 18.3, SD = 1.91). The main effect 
comparing the groups was not significant [F(3,324) = .156, p=.93], suggesting that provision 




Aide to retain 
mean (SD) 
Aide to return 
mean (SD) 
Checklist to return 
mean (SD) 
     
Time 1  17.21 (1.81) 17.67 (2.03) 17.50 (1.73) 17.45 (2.22) 
Time 2 18.39 (2.04) 18.26 (1.98) 18.32 (1.93) 18.36 (1.73) 
Table 4. Study 1 group mean self efficacy scores pre- and post intervention 
Subsequent analyses compared self-efficacy between those who returned FOBTs and those 
who did not. Table 5 shows that when we compared SE over time for FOBT non-returners 
using a paired samples t-test there was a decrease in confidence that approached significance 
(p=.08). In other words, the confidence of non-participants to screen was impacted negatively 
by the provision of the FOBT. By contrast, confidence among those who returned an FOBT 
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increased significantly, regardless of group assignment. This result suggests that, in general, 
confidence to complete the test in the future is likely to decrease for those people who don’t 
complete initial screening, regardless of initial level of confidence.  
 
 M SD df t 
SE score non-returners (full sample) Time 1 16.77 1.893 47 1.758 Time 2 16.15 2.278 
SE score returners (full sample) Time 1 17.57 1.944 279 8.674*** Time 2 18.71 1.561 
Low baseline SE score non-returners Time 1 15.46 1.208 25 0.220 Time 2 15.35 2.279 
Low baseline SE score returners Time 1 15.69 .978 116 15.388*** Time 2 18.32 1.711 
High baseline SE score non-returners Time 1 18.32 1.287 21 2.752** Time 2 17.09 1.925 
High baseline SE score returners Time 1 18.92 1.202 162 0.489 Time 2 18.99 1.383 
** p<.01 
***p<.001 
Table 5. Study 1 mean self efficacy scores pre- and post-intervention, overall and by 
return/non return of FOBTs 
In order to determine whether confidence at baseline influenced reaction to the various 
interventions, participants were characterised as having a low or high SE score at baseline 
(determined by a median-split between 16 and 17), and change in confidence over time 
compared (See Table 5). Low SE non-returners did not significantly change their SE scores 
post intervention, whereas low SE returners’ scores significantly increased post intervention. 
Similarly, for those with a high SE score at baseline, non-returners’ scores significantly 
decreased post intervention but did not significantly change if they returned an FOBT. This 
latter result is likely to reflect ceiling effects given that the maximum score possible for SE 
was 20. These results suggest that self efficacy was increased when the test was completed 
but the initial level of confidence to complete the test was low, and conversely confidence 
was decreased when the initial level was high but the test was not completed.  
3.4.4 Commitment to screen and maintain screening 
At baseline, the majority of people (n=217/343, 63%) were committed or very committed to 
doing the test (M=4.39, SD=.924; median=5) and there were no group differences (Table 6). 
Those who returned an FOBT were asked their level of commitment to maintain screening, 
and just over half (n=137/239, 57.3%) were “very committed” to screening again (M=4.38, 
SD=.840, median=5, n=47 missing values), regardless of intervention assignment. For those 
that did return an FOBT, a paired-sample t-test indicated that for the sample as a whole 
there was a statistically significant decrease in commitment to screen from baseline, ie after 
exposure to the intervention and FOBT (Table 7). When we examined the relationship 
between commitment and self efficacy by comparing commitment level between those who 
had a low or high SE baseline score, it was apparent that the decrease in commitment came 
from those that had a high initial SE score (Table 7). 
 
















     F, (df) p 
Time 1* 
(n=343) 





4.41 (.938) 4.33 (.816) 4.53 (.704) 4.24 (.878) 1.25  
(3,235) 
.294 
*Includes non-returners and returners; 7/350 missing values 
**Includes only those who returned an FOBT; 47/286 missing values 
Table 6. Study 1 mean commitment to screen by group pre- and post intervention 
 M SD df t 
Commitment to screen (full sample, n=233) Time 1 4.52 0.804 232 2.15* Time 2 4.38 0.843 
Low baseline SE score commitment to screen 
(n=99) 
Time 1 4.20 0.947 98 -1.522 Time 2 4.36 0.814 
High baseline SE score commitment to screen 
(n=134) 
Time 1 4.76 0.578 
133 4.485*** Time 2 4.39 0.866 
*<.05 
***<.001 
Table 7. Study 1 FOBT returners’ commitment to screen pre- and post-intervention, overall 
and by SE level at baseline 
3.4.5 Effect of self efficacy and commitment to screen on use of FOBT 
Logistic regression was used to assess the independent and joint effects of baseline SE and 
baseline commitment to screen on return of FOBT. SE alone made a statistically significant 
contribution, X2 (1, n=350)=11.535, p<.001, OR=1.27, CI 1.10-1.47), predicting 5.3% of the 
variance (Nagelkerke R squared) in screening uptake. Commitment to screen alone also 
made a statistically significant contribution X2 (1, n=343)=13.837, p<001, OR=1.67, CI 1.28-
2.18), and explained 6.4% of the variance. When these predictors were entered together into 
the logistic regression model, there was a statistically significant effect, X2(2, n=343)=17.487, 
p<.001), but only commitment to screen displayed a unique and statistically significant 
contribution (p=.012, OR=1.46, CI 1.07-1.97); baseline self efficacy was marginally significant 
(p=.06, OR=1.17, CI.993-1.37). This suggests that those who are committed to using the 
FOBT will do so regardless of their level of confidence. The total variance explained by the 
combined model was R2=8.0%, indicating that factors other than these also contribute to the 
likelihood of completing an FOBT.  
4. Study 2 
Study 2 was conducted to examine the generalisability of Study 1’s results to the broader 
population. This approach more closely approximated that undertaken in current 
population screening programs utilising FOBTs.  
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4.1.1 Sample size and selection 
Sample selection proceeded as described for Study 1. A separate sample of 6000 men and 
women aged between 50 and 76 years, randomly selected from four South Australian 
electoral divisions, was obtained from the AEC. People residing in postcodes included in the 
pilot NBCSP were omitted from the sample, as were those whose address indicated they 
resided in a hostel or nursing home. The remaining sample was randomised separately by 
sex and 400 men and women were assigned sequentially to one of 4 groups. In total 1600 
names were allocated. 
4.1.2 Study conduct 
Phase 1: All potential participants were mailed an advance notification letter (which aligns 
with the protocol adopted by the NBCSP) and accompanying information as for Study 1, 
and were informed that they would shortly be receiving a screening package in the mail. 
Exclusion due to ineligibility was dependent upon self-identification and communication of 
this fact to the researchers before despatch of FOBT. Willingness to participate was not 
deliberately ascertained. 
Phase 2: Three weeks after the advance notification letter, a screening kit including an 
immunochemical FOBT was sent to individuals. As for Study 1, intervention groups also 
received a discrete implementation plan. The nature of this approach precluded us from 
ascertaining willingness to participate and from obtaining pre- and post measures of self 
efficacy and commitment to screening.  
Phase 3: Receipt of completed FOBTs was recorded by the Bowel Health Service and 
participation data relayed to the researchers.  
4.1.3 Data analysis 
Participation rates were viewed as ‘early’ or ‘late’ at a cut-off point of 6 weeks following 
despatch of FOBT, when a reminder was sent to non-responders. Chi-square analysis was 
conducted to assess FOBT participation between groups.  
4.2 Results 
N=1600 men and women were sent an advance warning letter. Those who did not identify 
themselves as ineligible or not wishing to participate were then mailed a screening kit and 
accompanying material according to intervention group. In total, n=225 were excluded from 
the study (n=118 identified themselves as ineligible; n=83 didn’t wish to participate; n=24 
packages were undeliverable). Analyses were therefore conducted for n=1375 men and 
women. Recruitment and participation attrition rates are shown at Table 8. 
At baseline, the groups were balanced for gender (Table 9). It wasn’t possible to ascertain 
age group breakdowns because the AEC supplied a random sample within an age range 
(50–74 years) which wasn’t broken down into groups (for Study 1 we ascertained age from 
the participant). The study design also precluded us obtaining other demographic 
information (mean age, education, country of birth) as we did for Study 1. However, given 
that the underlying sampling mechanism was identical (i.e., supplied by the AEC), there is 
some confidence that the groups were balanced on these other factors. 
 

















they would shortly 
receive an FOBT 
kit. Ineligibility 





FOBT screening package only (n=400) 
(All groups, 
n=1375) 
Return of kit 
within and 
after 6 weeks 
 
Aide to retain 
FOBT screening package + implementation plan to 
be formulated and retained by participant (n=400) 
 
Aide to return 
FOBT screening package + implementation plan to 
be formulated and returned to researcher (n=400) 
 
Checklist to return 
FOBT screening package + implementation plan 
devised by researcher to be completed and 
returned to researcher (n=400) 

























X2 (3)=0.96,  
p=.992 
Table 9. Study 2 participant demographic characteristics  
4.2.1 FOBT participation 
Completed FOBTs were returned by 548/1375 (39.9%) of participants over a period of 26 
weeks (mean = 5.51 weeks). This rate is similar to that achieved in the NBCSP in 2008 (i.e., 
41% (AIHW, 2010). As for Study 1, contrary to our hypothesis that the formation of 
implementation plans would improve FOBT uptake, there was no significant difference 
between the groups in FOBT participation or return within 6 weeks (before and after 

























Return of kits 
within 6 weeks  
106 (30.7) 98 (28.0) 97 (29.0) 94 (27.2) X2 (3)=3.269, 
p=.352 
Return of plans 
with FOBT 
  83/131 
(58.4) 
62/142 (43.6) X2 (1)=9.389, 
p=.001 
Table 10. Study 2 overall return of kits and within 6 weeks (i.e. before reminder) by group 
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4.2.2 Return of implementation plans 
A considerable proportion of those who returned an FOBT and were also required to return a 
completed implementation plan did not do so, and significantly fewer people returned the 
prescriptive plan (i.e., checklist) than the aide (Table 10), suggesting that level of directedness 
may have an effect on whether the plans were completed—those who were required to 
formulate their own plan based on suggestions for action were more likely to return a plan 
compared to those given a prescriptive checklist. Notwithstanding this result, given that the 
requirement for return was to act as an indicator of whether plans had actually been 
formulated, it appears that around half the participants used the FOBT without adhering to 
planning instructions, particularly those who received a prescriptive plan.  
5. Discussion 
We hypothesised that the formation of implementation plans would assist return of FOBT 
kits by providing a physical cue to action. In addition we hypothesised that the process of 
completing a plan would increase confidence in ability to complete the test and that those 
who were strongly committed to screening at baseline would differ in formation of 
implementation plans and participation to those with a less strong initial commitment.  
Notwithstanding the difference in overall participation figures between Study 1 (81.7%) and 
Study 2 (39.9%), we found that for both studies provision of assistance with planning, 
regardless of directedness, had no influence on completion of an FOBT. The lack of 
influence of an implementation plan concurs with the conclusions of other researchers who 
have also found no effect of implementation planning on subsequent behaviour (Jackson et 
al., 2005; Michie et al., 2004; Rutter et al., 2006; Skar et al., 2011). Even so, this result goes 
against the large body of evidence suggesting that formulating action plans has a positive 
effect on the intention-behaviour gap. It has been suggested, however, that there exists 
sparse evidence for a positive effect of implementation intentions on behaviours outside 
student samples, who are more likely to comply with task demands (actually formulating 
the plan) (Jackson et al., 2005; Schweiger Gallo & Gollwitzer, 2007). It has also been argued 
that implementation plans are only effective where there is motivation to achieve a goal 
(Sniehotta, 2009) and that where goal intentions are positive, so will be the effects of 
implementation intentions (Gollwitzer, 1993; Oettingen et al., 2000). The majority of FOBT 
returners in Study 1 already had a high intention to screen, which may be attributable to the 
fact that that they had made a conscious decision to participate and were presumably more 
motivated to act, but in any case there was no evidence of a differential effect of combining 
high commitment with formation of implementation plans on FOBT return. Indeed, the high 
proportion of implementation plans returned by Study 1 participants (82%) may be 
indicative only of compliance with the study requirements (i.e., to return plans) rather than 
evidence of the use of these plans.  
However, and in contrast to Study 1, it is evident that nearly half the FOBTs returned in 
Study 2 were completed without making a plan, a result which could reasonably be 
extrapolated to the group that was asked to retain their formulated plan. It has been 
suggested that non-completion may reflect ambiguity of study instructions (Michie et al., 
2004) but, given that nearly all Study 1 participants returned identically-constructed 
implementation plans with a completed FOBT, this was not the case in our population. 
Rather, this outcome suggests that some felt they had no need to complete plans, perhaps 
because their intentions were sufficiently strong to make the use of plans unnecessary. 
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Indeed, we found from Study 1 that commitment had the most significant influence on 
FOBT use—because the majority of participants were strongly committed, we were unable 
to determine if having a weak level of commitment would influence formulation of an 
implementation plan or use of the FOBT. Of those Study 2 participants that did formulate 
and return plans, significantly fewer used the prescriptive ‘checklist’ format. Participants 
may have been “turned off” by the directedness of the checklist, particularly since they were 
a population sample and had not made a mindful decision to participate in a study. Study 1 
demonstrated that provision of directions did not increase people’s self efficacy. These 
results accord with a meta-analysis of 66 randomised controlled studies that concluded that 
forming implementation intentions had negligible effects on self efficacy and goal intentions 
(Webb & Sheeran, 2008).  
For the group as a whole, baseline self efficacy did not have a strong influence on whether 
people used the test; rather, the act itself of completing the FOBT determined 
confidence—self efficacy was increased when the initial level of confidence to complete 
the FOBT was low, and conversely confidence was decreased when the initial level was 
high but the test was not completed. Rather than confidence to use the FOBT, from Study 
1 it appears that being initially committed to screening had a more significant influence 
on whether people actually did use the FOBT, confirming the general consensus that 
intention to perform a behaviour is a necessary precursor of action. Even so, we found in 
Study 1 that commitment to screening, while a significant predictor of FOBT use, in 
conjunction with self efficacy explained only 8.0% of the variance, indicating that other 
factors exist which contribute to the likelihood of completing an FOBT. For example, 
Gregory et al. (2011) found that social-cognitive predictors of intention to screen for CRC 
and actual screening behaviour, although overlapping, were not the same, and Power and 
colleagues (2008) in their study of CRC screening found that life difficulty variables were 
better predictors of action than intention.  
It is puzzling to note that there was a significant decrease in commitment to repeat screening 
by those that did use the FOBT and had a high initial level of confidence, in contrast to those 
with low confidence whose level of commitment to screening did not change. It may be that 
initial commitment was high for most because the participants were an ‘interested’ sample, 
and that those with high SE who screened reinforced their view that they were capable of 
completing an FOBT without necessarily moving from that conclusion and forming a 
commitment to rescreen. Conversely, those with low confidence but who did complete their 
test, thereby increasing their confidence, could have felt ‘motivated’ to repeat the experience 
again and so not changed their level of commitment. Interestingly, the same lessening of 
intention by those with high self efficacy was noted in a study examining the role of self 
efficacy in testicular self-examination (Umeh & Chadwick, 2010). The researchers found that 
those with high self efficacy appeared to have worsened attitudes toward self examination 
when both vulnerability and severity estimates were low. The same situation could well 
apply to CRC screening, particularly as perceived susceptibility is a Preventive Health 
Model (PHM) construct demonstrated to be associated with CRC screening ((Flight et al., 
2010; Tiro et al., 2005). Commitment to future CRC screening in one or 2 years would 
perhaps, as Umeh and Chadwick (2010) have suggested, be temporarily rejected if the 
penalties of inaction are deemed insignificant, a viewpoint which may stem from a 
defensive reaction activated by anxiety. This view suggests that an emphasis on the 
development of messages designed to increase perceptions of personal risk of CRC without 
raising anxiety are warranted.  
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The low rate of participation in Study 2 may reflect a dissonance of messages appropriate to 
an individual’s stage of readiness to screen (Prochaska, 2008). The differences in study 
design, particularly recruitment strategy, between studies 1 and 2 may have resulted in 
basic sample differences in stage of readiness to screen at baseline. Specifically, including 
only participants prepared to complete questionnaires in Study 1 resulted in a highly 
committed sample, likely to be in contemplation or preparation to act stage, characterised by 
a high participation rate. By contrast, Study 2 invitees were a population sample, most of 
who were probably in pre-contemplation on receipt of the FOBT, with participation rates 
comparable with those achieved by the national screening program (i.e. ~ 40%). Pre-
contemplation is a stage where it could be argued that a person’s knowledge, attitudes and 
intentions are in a more unstable state. People in this stage have been shown to have higher 
barriers, higher chance health locus of control, low powerful others health locus of control, 
lower perceived susceptibility and lower CRC knowledge (Gregory et al., 2011). It follows 
that these factors should be addressed to facilitate movement through contemplation to the 
action stage. However, our implementation plans as formulated were aimed at those with 
an intention to act and focused on the where, when and how of successful completion of the 
FOBT. It could be daunting for those who had never heard of FOBT screening to receive a 
test and accompanying material designed to assist with completing the test without first 
being given information aimed at overcoming barriers and lack of knowledge associated 
with the pre-contemplation stage.  
6. Conclusion 
The provision of assistance with the preparation of implementation plans, regardless of their 
level of directedness, had no influence on FOBT participation in the 2 studies conducted. 
One reason for their lack of effect may be that the majority of participants were likely to be 
in pre-contemplation stage in Study 2 and in the action stage in Study 1. Thus ceiling effects 
limited the potential for cues to impact behaviour among participants in Study 1, and Study 
2 participants may have benefited from an intervention that tackled Contemplation as an 
intermediary to Action. This stage mismatch has implications for population-based 
screening programs and may contribute toward less than optimal screening uptake rates. 
Future research could usefully address the potential for the communication within a 
population setting of material targeted to specific decision stages, designed to progressively 
move an individual toward action and maintenance of action. Our research indicated that 
confidence to screen and commitment to screen separately and together exerted a greater 
influence on actual FOBT participation; however, these factors accounted for a small amount 
of variance and future research should address the contribution of other factors. 
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Cross-Cultural Validation of the Preventive 
Health Model for Colorectal Cancer Screening: 
An Australian Study
Ingrid H. Flight, MPH
Carlene J. Wilson, PhD
Jane McGillivray, DHSc
Ronald E. Myers, PhD
We investigated whether the five-factor structure of the Preventive Health Model for colorectal cancer 
screening, developed in the United States, has validity in Australia. We also tested extending the model with 
the addition of the factor Self-Efficacy to Screen using Fecal Occult Blood Test (SESFOBT). Randomly selected 
men and women aged between 50 and 76 years (n   414) responded to a survey. Confirmatory factor analyses 
indicated that the U.S. model provided adequate fit for the group as a whole and for men and women separately, 
thereby demonstrating cross-cultural validity for measuring factors influencing the decision to screen. The 
inclusion of SESFOBT in the model resulted in a comparable, but less parsimonious, fit. However, self-efficacy 
is a demonstrated mediator of intention and action, and it is argued that the addition of SESFOBT as a sixth 
factor may have utility for the design of strategies to increase actual uptake of FOBT.
Keywords: screening; construct validity; colorectal cancer; FOBT; preventive health model; Australia
In comparison to the United States, usual colorectal cancer (CRC) screening practice 
in Australia is by fecal occult blood test (FOBT, a home-based test that involves providing 
a smeared stool sample from two or three separate bowel movements to be sent to a labora-
tory to be analyzed for the presence of blood) followed by colonoscopy for those with a 
positive result—in other words, colonoscopy is regarded as a diagnostic test rather than a 
screening test. In 2007 the Australian federal government implemented the National Bowel 
Cancer Screening Program (NBCSP), which provided those turning 55 and 65 years with 
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a free FOBT kit. In 2008, the program was extended to include those turning 50 years. The 
uptake rate during 2008 was 39% of the eligible population (Australian Institute of Health 
and Welfare & Australian Government Department of Health and Ageing, 2009). Uptake 
also differed by sex (participation in the NBCSP was significantly higher for women, 42%, 
compared to 36% for men). These less than optimal rates highlight the size of public health 
challenge. How do we optimize participation rates using publicly delivered rather than 
clinician-based interventions?
An understanding of the variables that encourage people to participate in CRC screen-
ing using FOBT is important for a number of reasons. Early detection and treatment of 
precancerous lesions and adenomas results in a significantly higher survival rate than if 
treatment is delayed until physical symptoms of the conditions are evident. The cost 
effectiveness of FOBT screening for CRC (measured as Quality Adjusted Life Years 
gained) is comparable to other screening procedures and more cost-effective than treat-
ment administered after physical symptoms are evident and the cost effectiveness of FOBT 
screening is expected to increase as increasing participation and subsequent follow-up 
improves longer-term survival rates (Whynes, 2003).
The design of behavioral interventions that can substantially influence population use 
of CRC screening should be informed by an understanding of knowledge, attitudes, and 
perceptions of screening that are amenable to change. However, few studies have examined 
the reliability and validity of scales designed to measure psychosocial constructs specifi-
cally associated with CRC screening (McQueen, Tiro, & Vernon, 2008; Rawl, Champion, 
Menon, & Skinner, 2001; Ritvo et al., 2008; Tiro, Vernon, Hyslop, & Myers, 2005; Vernon, 
Myers, & Tilley, 1997). In the United States, Vernon and colleagues (1997) developed and 
validated a series of CRC screening scales and items derived from earlier work on the 
development of scales to measure adherence to cancer screening guidelines (DiMatteo 
et al, 1993; Jepson, 1990). Their scales were based on the preventive health model (PHM), 
which has been shown to predict intention and behavior for CRC screening (Watts, Vernon, 
Myers, & Tilley, 2003). The PHM constructs were Salience and Coherence (the perception 
that performing a health behavior is consistent with beliefs about how to protect and maintain 
health), Perceived Susceptibility (subjective personal risk for developing colorectal cancer 
or polyps), Response Efficacy (the belief that adopting a behavior will be effective in 
reducing disease threat), Cancer Worries (concerns about negative consequences of com-
pleting the behavior), Social Influence (perceived beliefs about and desire to comply with 
key references’ attitudes toward the behavior), and Self-Efficacy (an individual’s belief in 
his or her ability to overcome barriers associated with screening). Subsequently, Tiro et al. 
(2005) in the United States analyzed data that validated five of the PHM constructs, which 
they termed the general colorectal cancer screening measurement model (Self-Efficacy 
was omitted): They were particularly interested in whether the model demonstrated factorial 
invariance between men and women and different racial and ethnic groups (i.e., the scale 
scores of the factors were comparable when administered to different groups). Their results 
confirmed that the five-scale model provided excellent fit and was invariant across race 
and sex subgroups. A similar study, undertaken in Canada (Ritvo et al., 2008), concluded 
that the five-factor model was invariant in a population of both men and women in Ontario, 
once the model was redefined with two error covariance terms for the social influence 
construct. Shared error variance between survey items measuring the same construct is a 
common finding among scales measuring attitudes and beliefs (Byrne & Baron, 1993).
The earlier investigation (Vernon et al., 1997) also included the construct Self-Efficacy. 
Self-Efficacy was not included in the subsequent U.S. and Canadian analyses, because 
the research focus was on CRC screening behavior independent of the specific screening 
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test employed. Self-efficacy is generally measured in terms of confidence to perform a 
very defined act, such as utilization of a specific type of cancer screening (e.g., colonos-
copy), rather than confidence in ability to engage in a behavior that is more broadly 
defined (e.g., screening for colorectal cancer). Elsewhere, however, self-efficacy has been 
shown to be a significant predictor of health-related behaviors, including both intention 
(e.g., Frank, Heiby, & Lee, 2007) and actual behavior (e.g., Everett, Salamonson, & 
Davidson, 2009). For this reason, and because we were interested in participation in 
screening utilizing the FOBT, we included the construct Self Efficacy to Screen with 
FOBT (SESFOBT) in a model designed to measure cognitive and behavioral factors 
influencing CRC screening decision making in the Australian population.
In summary, the objectives of the study were (a) to assess whether the five-factor 
structure for items developed by Tiro et al. (2005) as an extension of earlier work in the 
United States could be replicated with an Australian population at average risk of CRC 
(i.e., the only risk is age !50 years) and (b) to determine whether a sixth factor addressing 
self-efficacy to screen using FOBT could be usefully added to the model.
MATERIALS AND METHODS
Development of Survey Instrument
Five factors (Salience and Coherence, Cancer Worries, Perceived Susceptibility, 
Response Efficacy, and Social Influence) were measured by 16 items, reproduced from 
Tiro et al.’s (2005) study. The 16 items were scored on a 5-point Likert-type scale ranging 
from strongly disagree to strongly agree. In addition, we developed six items to measure 
SESFOBT. These items were derived from the self-efficacy items developed by Vernon 
et al. (1997) and our clinical experience of the challenges and impediments surrounding 
FOBT use, particularly embarrassment and distaste. Participants were asked to rate their 
degree of confidence in surmounting the barriers described. The six items were scored 
on a 5-point Likert-type scale ranging from not at all confident to very confident. The 
items, their assignment to constructs, and descriptive statistics are provided in Table 1. 
The survey included six demographic questions describing age, sex, marital status, edu-
cational attainment, place of birth, and current residential postcode (knowledge of suburb 
postcode enabled economic status, as defined by level of income, to be determined through 
the use of socioeconomic indices).
Participants and Procedures
It is generally accepted that for confirmatory factor analyses, each variable should be 
represented by at least five participants and double this number if factors are defined by 
few variables (Gorsuch, 1983). Accordingly, we planned to recruit a minimum sample 
size of n   352 (176 men and 176 women; n   8, respectively, for each of 22 variables). 
Assuming a 35% response rate, we approached 1,000 potential participants.
To identify those potential participants, a random sample of 3,000 men and 3,000 
women aged between 50 and 76 years from four South Australian electoral divisions was 
provided by the Australian Electoral Commission. Data were provided in the form of sex, 
name, and registered address. The sample was again randomized separately by sex using 
a random number generator (Microsoft® Office Excel 2003) and telephone contact num-
bers obtained by comparing the list against information contained in the electronic White 
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Pages telephone directory. Those persons for whom telephone contact details were not 
provided were excluded from the list, as were those whose address indicated that they 
resided in a hostel or nursing home; such individuals are unlikely to be in the position 
of deciding for themselves whether they should screen for CRC. The first 500 men and 
500 women out of a total of n   2,379 remaining on the list were sent an introductory 
letter explaining the nature of the study and advising them that they would be contacted 
by telephone with an invitation to respond to a number of statements. In the introductory 
letter and at subsequent telephone contact, potential participants were advised that they 
were ineligible to participate if they had ever been diagnosed with CRC or polyps, or 
had a colonoscopy or sigmoidoscopy to check for CRC within the past 10 years. The 
latter exclusion criterion was necessary because, as mentioned previously, in Australia 
these procedures are not regarded as screening for CRC but are normally conducted as 
diagnostic measures following a positive FOBT. Ethics approval of the study was obtained 
from the Human Ethics Committee of the Commonwealth Scientific and Industrial 
Research Organisation.
Survey Administration
A computer-assisted telephone interview (CATI) was undertaken by trained interview-
ers during June 2006. Data were captured utilizing Microsoft Office Access 2003. For 
those contacted who were eligible and agreed to participate, informed consent was for-
mally requested and recorded before commencement of the CATI. The participant provided 
demographic information and was asked to respond to a series of 16 statements compris-
ing the 5 construct items used by Tiro et al. (2005), which address CRC screening in a 
general sense (Table 1). The interviewer then described an FOBT (“A fecal occult blood 
test, or FOBT, is a test to check for colorectal cancer. It is done at home using a set of 
cards. You smear a sample of your fecal matter or stool on a card from two or three 
separate bowel movements, and return the cards to be tested for the presence of blood. 
If the test is positive, it does not mean that you have bowel cancer, only that blood has 
been detected in the stool sample.”). Following this description, participants were asked 
to respond to a series of statements comprising the SESFOBT factor (Table 1). They 
were also asked if, prior to being read the FOBT description, they had ever heard of the 
test and if so what their FOBT screening intentions were.
Data Analysis
We used independent samples t test to compare gender groups on age, and computed 
chi-square test statistics to compare men and women on sociodemographic factors. Cron-
bach’s alpha was used to determine the internal reliability of the scales. Confirmatory factor 
analyses were conducted on the group as a whole and, if fit was acceptable, by sex, to assess 
the validity of the five-factor model, including the two error covariance terms proposed by 
Ritvo et al. in Canada (2008). We also assessed the fit of a six-factor model comprising the 
five general factors plus SESFOBT. To assess goodness of fit, we used incremental fit indices 
(comparative fit index [CFI]), absolute fit indices (root mean square error of approximation 
[RMSEA]), and parsimonious fit indices (Akaike information criterion [AIC]). Adequate to 
good fit has been defined as a CFI ≥ .90 and an RMSEA value ≤ .05 (Hu & Bentler, 1999). 
When comparing model fit, a smaller AIC value indicates a more parsimonious fit, all other 
things being equal. Missing values were addressed using the full information maximum 
likelihood (FIML) method. Confirmatory factor analysis was undertaken using AMOS 7.
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RESULTS
From 1,000 potential participants sent an introductory letter, n  146 were uncontactable 
and n   245 declined to participate. A further n   185 of those contacted were ineligible 
and n   10 withdrew during the interview, leaving a total remaining sample size of n   414 
(n   197 men; n   217 women). Thus, we exceeded our planned sample size. There were 
no significant demographic differences between male and female participants for age (mean 
age   62.2 years), highest level of education (the majority, 62%, had left before completing 
high school), country of birth (68% were born in Australia), or income level (41% of the 
total sample resided in areas with income levels !0.66 percentile). Women were less likely 
to be married and more likely than men to be widowed or separated (F2 (2)  8.378, p  .015). 
The majority of participants (70%, n   289) had never heard of FOBT until described to 
them at interview; 14% (n   59) indicated they had heard of FOBT but had not actively 
considered screening; and 9% (n   37) indicated that they had heard of FOBT and intended 
to use the test in the future. The remainder had considered screening but was undecided, 
had actively decided not to use FOBT or were screening regularly, every 2 years.
Total and subgroup checks for internal reliability were computed using Cronbach’s α 
(Table 1). Total internal reliability was high for the SESFOBT scale (.88), but only mod-
est for each of the five original variables (ranging from .53 for social influence to .68 for 
perceived susceptibility). Two items showed poor internal consistency, with scale reli-
ability improved by their deletion. Both items were reverse scored. The first, Item 6, 
“I will be just as healthy if I avoid having colorectal cancer screening,” correlated only .31 
with total score on the Salience and Coherence scale, and the second, Item 12, “Compared 
with other persons I’m at lower risk for colorectal cancer,” correlated .28 with total score 
on Perceived Susceptibility. These items also had low factor loadings (Table 3). This 
suggests that the negative wording may have created some conceptual confusion among 
respondents.
Single group confirmatory factor analysis (Figure 1, Table 2) revealed that the instru-
ment validated in the United States (Tiro et al., 2005), with the inclusion of the two error 
covariance terms for the social influence construct defined by Canadian researchers (Ritvo 
et al., 2008; “I want to do what my doctor or health professional thinks I should do about 
colorectal cancer screening: Members of my immediate family think I should have colorec-
tal cancer screening” and “My doctor or health professional thinks I should have colorectal 
cancer screening: I want to do what members of my immediate family think I should do 
about colorectal cancer screening”), was an adequate fit for the Australian data (CFI for 
full sample   .940, RMSEA   .041; Table 2, Model 1).
Adding a sixth factor, SESFOBT, to the model resulted in a less robust fit, with the CFI 
dropping to .914 (Table 2, Model 2). However, after examining the modification indices, 
we found three error covariance terms in this scale with large chi-square values: Cndistastfl 
(“I am confident that I would not find the test distasteful”) and Cnembarrsng (“I am con-
fident that I will not find using the kit embarrassing”); Ctime (“I am confident that I would 
find the time in the day to complete the test”) and Ccorrect (“I am confident that I could 
complete the test correctly”); and Cnembarrsng and Ctime. When these terms were added, 
the six-factor model fit was significantly improved (p  .001; Table 2, Model 3) and com-
parable to the five-factor model fit, with a CFI of .950 and RMSEA .039. Standardized 
factor loadings for Model 3 are shown in Table 3.
The confirmatory factor analysis of the six-factor model, including the three covari-
ance terms, indicated adequate fit for the group as a whole. Sex-specific confirmatory 
factor analyses were also undertaken; model fit was adequate for both men and women. 
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However, the AIC for the group as a whole and for men and women separately was larger 
for Model 3 compared to Model 1 (Table 2).
DISCUSSION
The five-factor general colorectal cancer screening measurement model validated 
in the United States (Tiro et al., 2005) and Canada (Ritvo et al., 2008) appears to be an 
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Figure 1. Single Group Six-Factor Preventive Health Model for Colorectal Cancer Screening
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Overall, for both our study and Tiro et al.’s study (2005), the internal reliability for the 
original five constructs was lower than the recommended level of .7 (Cortina, 1993), which 
Tiro and colleagues attribute to the small number of variables used to operationalize each 
construct. Future research should address identification of additional items that could 
improve the precision of construct assessment to facilitate intervention development. 
Internal consistency statistics for two scales, Response Efficacy and Social Influence, 
were particularly low (.54 and .53, respectively). Response Efficacy comprises two items, 
both of which could be regarded as testing a person’s health knowledge rather than reflect-
ing their beliefs about the ability of the test to detect an abnormality. Ritvo et al. (2008) 
have suggested that social influence is determined by both knowledge of others’ attitudes 
and motivation to comply with these; our observations are consistent with this interpreta-
tion. The inclusion of additional items that distinguish effective referents for social influ-
ence could improve reliability.
The additional factor SESFOBT contained six statements with high reliability (.88). 
Inclusion of this sixth factor with three additional covariances (Table 2, Model 3) resulted 
in a comparable fit to the five-factor, two-covariate model (Table 2, Model 1). However, 
the larger AIC value for Model 3 indicates that it has a less parsimonious fit compared to 
Model 1. Self-Efficacy as a construct is conceptually distinct from the other factors in that 
it measures confidence to overcome currently perceived barriers affecting compliance 
(in this case, using an FOBT kit). Power and colleagues (2008) found that whereas social 
cognitive variables, such as perceived benefits, risks, and fears, were important determinants 
Table 3. Model 3 Factor Loadings (Standardized)
  Whole Sample Men Women 
Factor Item Item No.  (n   414) (n   197) (n   217)
Salience and coherence 1 .58 .59 .58
 3 .73 .71 .76
 4 .70 .67 .72
 6a .35 .34 .38
Cancer worries 5 .55 .55 .54
 8 .89 .94 .88
Perceived susceptibility 11 .67 .69 .63
 12a .31 .24 .43
 13 .67 .66 .70
 15 .76 .85 .68
Response efficacy 14 .44 .45 .64
 16 .84 .84 .55
Social influence 2 .48 .37 .53
 7 .69 .74 .69
 9 .52 .62 .42
 10 .49 .41 .54
Self-efficacy for FOBT 17 .77 .84 .70
 18 .85 .93 .75
 19 .74 .75 .73
 20 .77 .81 .74
 21 .64 .62 .67
 22 .73 .80 .66
NOTE: FOBT = fecal occult blood test.
a. Items were reverse coded.
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of intention to screen (in their study, by colonoscopy) for CRC, barriers they termed “life 
difficulty variables” (defined as socioeconomic deprivation and poor health status) were 
more strongly associated with actual screening. An acknowledged limitation of their study 
was that they did not have a measure of self-efficacy, and they argued that confidence 
might explain the influence of the life difficulty variables on screening attendance.
Self-efficacy can also strengthen the knowledge–behavior link: Although an individual’s 
knowledge of screening and its importance may be optimal, if perceived lifestyle change 
barriers remain high, such knowledge is unlikely to translate into actual behavior (Rimal, 
2000). Thus, notwithstanding the increased complexity of our model and its failure to 
improve fit, adding SESFOBT to the PHM could have utility for the design of interventions 
that enhance self-efficacy to actually screen, thereby providing a stronger focus on action 
rather than intention (Power et al., 2008).
LIMITATIONS OF THE STUDY
The Australian model did not achieve the same level of CFI or RMSEA statistics as 
reported in the U.S. study (Tiro et al., 2005), but even so it does demonstrate comparabil-
ity for the group as a whole and for men and women separately. The difference in results 
may reflect differences in the targeted participants: primary care clinic patients in the 
United States and the general population aged 50 to 76 years in Australia. Nonetheless, 
the model fit remained adequate regardless of the difference in population and reference 
screening technology, and so this observation does not constitute a fatal flaw of the study. 
Although the models tested had highly significant chi-square results (Table 2), the likelihood-
ratio chi-square statistic is regarded as being overly sensitive when a sample exceeds 
200 respondents, as it did in both our and Tiro et al.’s (2005) study (Hair, Anderson, 
Tatham, & Black, 1998).
The questionnaire was also limited by the manner in which potential threats to con-
fidence were defined within the self-efficacy measure. Nonetheless, we would argue that 
further explanation of barriers to self-efficacy must be addressed in order to facilitate 
optimal conversion from intention to action. The importance of this is reinforced by the 
international differences in CRC screening practices, suggesting that the PHM model 
might be enhanced by the development of advice on strategies for improving an indi-
vidual’s confidence in complying with the specific testing requirements.
IMPLICATIONS FOR PRACTICE
Our results indicate that the five-factor general colorectal cancer screening model, 
based on preventive health model constructs, has utility for measuring factors influencing 
the decision to screen for CRC in the Australian population and hence can be used for the 
development of interventions and strategies to improve screening uptake in Australia. 
Practitioners advising individuals about the importance of screening for CRC should 
address perceptions of the salience and coherence of the screening by addressing each of 
the following; highlight the effectiveness of early identification of precancerous adenomas, 
describe how CRC risk is linked to age and lifestyle and that susceptibility is real; explain 
the effectiveness of the current regime for CRC screening within the country (i.e., response 
efficacy); address cancer worries so that these serve to motivate rather than inhibit action, 
and highlight the widespread participation of others from their age cohort and the nature 
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of current health authority recommendations (i.e., utilizing social influence). We would 
suggest that optimizing a potential participant’s intention to screen by addressing each of 
these factors is critical to achieving informed decision making. In addition, moving com-
mitted individuals to action may be best facilitated by helping them address any uncertainties 
they may have about their ability to comply with the screening requirements (i.e., improv-
ing self-efficacy). This may require identifying individual barriers to test utilization such 
as feces aversion, procrastination, and perceived embarrassment or inconvenience. Utiliza-
tion of the scale on an individual basis provides a means of quickly identifying which of 
the six variables described above might serve to inhibit participation, thereby facilitating 
intervention.
CONCLUSION
The five-factor preventive health model for colorectal cancer screening, developed 
in the United States, has validity in Australia. Although the five PHM construct scales 
have been demonstrated to possess good properties, their low internal consistency in both 
the U.S. and Australian studies indicates the potential for further development to improve 
measurement precision. The addition of the factor Self-Efficacy for using FOBT to the 
PHM results in a comparable but less parsimonious fit. Nevertheless, inclusion may be 
appropriate where FOBT is the primary screening option, as the model could have added 
utility for the design of interventions to enhance self-efficacy for actual use of home-based 
testing, compared to intention to use. Notwithstanding the high internal consistency and 
strong factor loadings for the self-efficacy items, given that they represent different concerns, 
future research should consider whether these items too could benefit from refinement.
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Abstract
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and the second in females
throughout the developed world. Population screening using fecal occult blood tests (FOBTs) facilitates early detection and
greater chance of survival, but participation rates are low. We developed a Web-based decision tool to provide information tailored
to an individual’s decision stage for CRC screening and attitude toward screening utilizing the Preventive Health Model (PHM)
and Precaution Adoption Process Model (PAPM) as theoretical frameworks for screening behavior. We describe the practical
steps employed in the tool’s design and the subsequent conduct of an exploratory study.
Objective: To design a decision tool for CRC screening and conduct an exploratory study among average-risk men and women
to (1) test the impact of message type (tailored vs non-tailored) and message delivery modality (Web-based vs paper-based) on
attitudes toward screening and screening uptake, and (2) investigate the acceptability of the decision tool and relevance of
materials.
Methods: Participants (n = 100), recruited from a population sample of men and women aged 50-76 residing in urban Adelaide,
Australia, were randomly assigned to a control group or one of 4 interventions: (1) Web-based and tailored information, (2)
paper-based and tailored information, (3) Web-based and non-tailored (generic) information, or (4) paper-based and non-tailored
information. Participation was augmented by snowball recruitment (n = 19). Questionnaires based on PHM variables were
administered pre- and post-intervention. Participants were given the opportunity to request an FOBT. Following the intervention,
participants discussed the acceptability of the tool.
Results: Full data were available for 87.4% (104/119) of participants. Post-intervention, perceived susceptibility scores for
individuals receiving tailored information increased from mean 10.6 (SD 2.1) to mean 11.8 (SD 2.2). Scores on self-efficacy
increased in the tailored group from mean 11.7 (SD 2.0) to mean 12.6 (SD 1.8). There were significant time x modality x message
effects for social influence and salience and coherence, reflecting an increase in these scores for tailored Web-based participants
only; social influence scores increased from mean 11.7 (SD 2.6) to mean 14.9 (SD 2.3), and salience and coherence scores
increased from mean 16.0 (SD 2.2) to mean 17.7 (SD 2.1). There was no greater influence of modality or message type on
movement toward a decision to screen or screening uptake, indicating that neither tailored messages nor a Web modality had
superior effect. Overall, participants regarded tailored messages positively, but thought that the Web tool lacked “media richness.”
Conclusions: This exploratory study confirms that tailoring on PHM predictors of CRC screening has the potential to positively
address attitudes toward screening. However, tailoring on these variables did not result in significantly increased screening uptake.
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Future research should consider other possible psychosocial influences. Mode of delivery did not affect outcomes, but as a delivery
medium, the Web has economic and logistical advantages over paper.
(JMIR Res Protoc 2012;1(2):e12)   doi:10.2196/resprot.2135
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Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed
cancer in males and the second in females throughout the
developed world [1]. Population screening using a fecal occult
blood test (FOBT), or the second-generation fecal
immunochemical test (FIT), facilitates the detection of CRC at
its early stages by detecting invisible (occult) traces of blood
in the feces. A recent systematic review concluded that
appropriate population utilization of FOBT screening is likely
to reduce death from CRC by about 1 in 6 deaths [2]. This
possibility has resulted in the implementation of national pilot
or population screening programs in a number of countries [3].
Effectiveness of these programs depends upon yield and
participation rates—in Australia, estimates of participation in
screening for colorectal cancer have been low [4]. The National
Bowel Cancer Screening Program (NBCSP), which provides
people turning 50, 55, and 60 years with a free FOBT, had a
total participation rate over three years (June 2008 to June 2011)
of 38.4% of the eligible population [5].
This paper describes the theoretical framework and practical
steps we employed to design a Web-based, tailored decision
tool for CRC screening, and to conduct an exploratory study to
test its impact on screening attitudes and uptake prior to the
design and conduct of a larger randomized trial. We examined
uptake of FOBT only (versus colonoscopy or in addition to
colonoscopy) because unlike other countries, such as the United
States, usual CRC screening practice in Australia is by FOBT
followed by colonoscopy for those with a positive
result—colonoscopy is regarded as a diagnostic test rather than
a screening test. We also sought to place the study in the context
of the NBCSP approach, which is to encourage population-based
screening using FOBT for those who do not have any obvious
symptoms of bowel cancer.
Theoretical Framework
Two classes of behavioral theory are relevant to understanding
uptake of new health behavior. “Stage of change” or “readiness
to act” models, such as the Precaution Adoption Process Model
(PAPM) [6], focus on an individual’s commitment to act. The
PAPM characterizes movement toward commitment as (1)
unaware of the issue, (2) heard of the issue but unconcerned,
(3) considering action, (4) deciding against action, or (5)
deciding to act. By contrast, “continuum” theories, such as the
Preventive Health Model (PHM) [7], focus on psychosocial
predictors of intention to act and on predictors of behavior. The
PHM approach identifies 5 variables that affect the likelihood
to act. In the context of cancer screening, these are (1) salience
and coherence of the screening behavior (the perception that
performing cancer screening is consistent with beliefs about
how to protect and maintain health); (2) perceived susceptibility
(perceptions of personal risk for developing colorectal cancer
or polyps); (3) response efficacy (the belief that utilizing an
FOBT will be effective in reducing disease threat); (4) cancer
worries (concerns about negative consequences of undertaking
cancer screening); and (5) social influence (extent to which an
individual believes that those who they interact with, and whose
opinions they value, support FOBT use). Research indicates
that these factors are associated with the decision to screen in
the United States [8], Canada [9], and Australia [10]. Two other
constructs—self-efficacy and fecal aversion—are important in
the context of this study. Self-efficacy, in this case the
confidence to utilize the FOBT, is a significant predictor of
health-related intentions [11] and behaviors [12], and fecal
aversion has been demonstrated to be a predictor of FOBT
uptake [13].
Research has shown that programs designed to improve
screening uptake are enhanced considerably when stage theories
and continuum theories are utilized together. Groups of people
at a specific stage of thinking about CRC screening (PAPM)
can be distinguished from people at a different stage in terms
of their responses to the variables included in the PHM [14,15].
Thus, utilization of both the PAPM and PHM can enable the
provision of messages that are “tailored” to individual responses
with the aim of moving people to a “better” screening decision
stage.
Tailored Communication
Tailored health promotion materials are “...any combination of
information and behavior change strategies intended to reach
one specific person, based on characteristics that are unique to
that person, related to the outcome of interest, and derived from
an individual assessment” [16]. Tailored print communication
is better remembered, read, and perceived as more relevant than
non-tailored materials [17]. However, a recent systematic review
based on two trials, found no evidence of tailored interventions
on CRC screening uptake [18], although the researchers found
evidence for a beneficial effect of tailored information on
perception of cancer risk and knowledge of cancer. Thus, further
research is required to better understand the “ingredients” of
tailoring approaches on CRC screening rates.
Web Delivery of Information
Paper-based delivery of non-tailored screening messages has
improved FOBT uptake [19,20] and tailoring may have the
capacity to achieve further incremental improvements in uptake
rates. A meta-analysis showed that computerized tailoring
(feedback composed by means of computer algorithms)
demonstrated improved outcomes in terms of health behaviors
compared to controls [21]. Using computers to construct tailored
messages can facilitate the creation of finer-grained tailored
materials; without them, tailoring has been limited to few
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variables because of constraints on the logistical practicality of
creating a comprehensive library of messages and manipulating
them to simultaneously address multiple variables [22].
Additionally, delivery via online communication channels may
increase the feasibility of this individualized approach to
communication through channels such as interactive feedback
and simplicity of navigation to personally relevant materials.
For example, a meta-analysis comparing Web-based and
non-Web-based information interventions has shown enhanced
outcomes among individuals using Web-based interventions,
particularly in the areas of knowledge and targeted behavior
change [23].
In light of the above considerations, we conducted an
exploratory study to investigate whether information tailored
to an individual’s current decision stage for screening based on
PHM variables would have a greater influence on the readiness
of invitees to be screened compared with non-tailored generic
information. We also sought to disentangle outcomes and
investigate whether it was perceived personal relevance (through
tailoring) of information, simplicity of navigation (through
Web-based delivery) to access personally relevant material, or
both factors that had the greater effect. The primary outcomes
were (1) change in PHM scores, (2) change in PAPM decision
stage, (3) intention to screen as measured by a request for an
FOBT, and (4) actual uptake of screening. We were also
interested in participants’ opinions of the acceptability and
relevance of the materials. We aimed to use results from this
exploratory study to inform the design and conduct of a larger,
nationwide randomized controlled trial.
Methods
Study Design
A 2 × 2 × 2 mixed model factorial design examined the influence
of message type (tailored vs non-tailored) and message modality
(paper vs Web) on predictors of screening (PHM variables) and
stage of readiness to screen (PAPM stage) measured before and
after receipt of screening messages. We planned to contact at
least 750 participants to achieve a sample size deemed practical
for an exploratory study (n = 125).
Pre-intervention (Time 1)
A baseline survey was taken 2 weeks before intervention. The
variables measured were demographics, decision stage for
screening, decisional conflict, PHM, and self-efficacy and fecal
aversion variables.
Intervention
Intervention group participants received one of 4 interventions:
(1) Web-based and tailored information, (2) paper-based and
tailored information, (3) Web-based and non-tailored (generic)
information, or (4) paper-based and non-tailored information.
The factorial design is illustrated in Table 1.
Table 1. Information supplied to intervention group participants based on message type and modality.
MessageModality
Non-tailoredTailored
Generic information and educational materialPHM feedback and educational materialWeb
Generic information and educational materialPHM feedback and educational materialPaper
Post-intervention (Time 2)
An endpoint survey and interviews immediately followed
intervention. Variables measured were decision stage for
screening, decisional conflict, relevance and navigability of the
information, PHM, and self-efficacy and fecal aversion
variables.
Participant Recruitment
A random subsample of 756 potential invitees aged 50-76,
residing in four urban Adelaide areas, were selected (with
permission) from a larger sample provided by the Australian
Electoral Commission for a related study. Prior to extracting
this subsample, telephone contact numbers were obtained by
comparing names and addresses against information contained
in the electronic White Pages telephone directory. Those persons
for whom telephone contact details were not indicated were
excluded, as were those whose postal code indicated they lived
more than one hours’ travel time from the Commonwealth
Scientific and Industrial Research Organisation (CSIRO)
laboratories. The remaining names were randomized into 4
intervention groups and 1 control group by a researcher not
directly connected with the study using a computer-generated
random number sequence (Microsoft Office Excel 2003).
Study Conduct
The trial commenced in August 2007 and proceeded through a
number of phases.
Phase 1
A notification letter describing the study was mailed to potential
participants. They were advised that they were eligible to
participate if they were aged 50-76 and ineligible if they were
having regular CRC screening or had ever been diagnosed with
colorectal cancer or bowel polyps. Those allocated to the
intervention groups were also required to have experience using
a computer to search the Web and to be willing to attend the
CSIRO laboratory.
Phase 2
Two weeks (+/- 48 hours) following the notification letter,
attempts were made (maximum 3) to telephone individuals and
recruit them to the study. A computer-assisted telephone
interview (CATI) format was used to collect interview responses
(Microsoft Office Access 2003). Informed consent was formally
requested and recorded before commencement of the CATI.
Participants answered baseline survey questions to collect
background demographics and responses to other variables as
described previously. Appointments were made with all but the
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control group participants to visit the CSIRO laboratory and
review materials concerned with CRC screening.
Phase 3
Two weeks (+/- 48 hours) later, participants attended CSIRO.
They were presented with Web-based or paper-based CRC
educational content, as allocated by random sampling, to work
through as they wished. Additionally, one Web group and one
paper group received messages tailored according to their
responses to the baseline survey. The non-tailored Web and
paper groups received generic information. Participants in each
group were aware that the intervention might be Web- or
paper-based, but those who received tailored messages were
blinded to the fact that others received only generic messages.
The process of developing the tailored messages and educational
content is described in the Materials section. Participants were
also given the opportunity to request an FOBT through either
a Web link or a paper form according to intervention group.
Phase 4
Immediately following the intervention, participants were asked
to complete an endpoint survey that remeasured the same
variables as in the baseline survey. Control group participants
were telephoned at this point (ie, approximately 2 weeks
following the baseline survey) and they completed the endpoint
survey through a CATI. Control group respondents whose
PAPM stage was “ready to act” were regarded as having
requested an FOBT kit. Those who were not ready to act were
sent a letter inviting them to contact the researchers should they
subsequently wish to receive an FOBT.
Phase 5
All intervention group participants completed an additional
questionnaire and participated in a discussion group immediately
following completion of the endpoint survey. Both the
questionnaire and the discussion explored perceptions of the
relevance of the information presented, ease of navigation
through the materials, and satisfaction with the information they
had gained. The interviews were conducted individually or as
a group, depending on the number of people attending the
session. The questionnaire analyses are not included here
because they have been reported in a separate paper with respect
to an enhanced version of the decision aid [24].
Phase 6
One day after the intervention, an FOBT was mailed to those
who requested one. The remaining participants were sent a letter
inviting them to contact the researchers should they subsequently
wish to receive an FOBT. Receipt of completed tests was
recorded by a processing center and de-identified with aggregate
participation data relayed to the researchers. People who did
not return their test after 6 weeks were sent a reminder letter.
Those who did not return their test after 12 weeks were regarded
as having not screened.
Materials
An overview of the materials developed for the study and their
presentation is described subsequently, followed by specific
details of the various components.
Tailored Intervention
Materials for the tailored group were a message library
consisting of messages tailored to an individual user’s decision
stage for screening and responses to PHM, self-efficacy, and
fecal aversion variables, and generic educational content based
on the NBCSP consumer information booklet. The booklet
provided generalized risk information (ie, > 50 years, certain
bowel conditions, and family history).
Non-tailored Intervention
Materials for the non-tailored group were a series of generic
messages addressing susceptibility, response efficacy, social
influence, self-efficacy and fecal aversion, and generic
educational content as described above.
Web Group
Educational content was provided in hyperlink format with
discrete sections. Web pages were clean and used plain language
with bulleted and numbered lists, generous white space and line
spacing, and large navigation indicators. Users had the ability
to increase font size and to change contrast. A Web link
provided the ability to order an FOBT.
Paper Group
Educational content was provided in booklet form with discrete
sections prefaced with a table of contents. Pages were clean and
used plain language with bulleted and numbered lists, and
generous white space and line spacing. A self-complete form
provided the ability to request an FOBT.
Questionnaire
A series of statements based on PHM [8,7], self-efficacy, and
fecal aversion variables were prepared (Table 2). Self-efficacy
was measured using 3 statements derived from previous research
regarding FOBT use [7]. Fecal aversion was measured using 3
statements derived from previous research [13]. All scales had
acceptable internal consistency as measured by Cronbach alpha
(Table 2). All responses were measured on a 5-point Likert scale
ranging from “strongly disagree” to “strongly agree.”
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Colorectal cancer screening makes sense to me..73Salience and coherence
Having colorectal cancer screening is an important thing for me to do.b
Having colorectal cancer screening can help to protect my health.
I will be just as healthy if I avoid having colorectal cancer screening.c
I want to do what members of my immediate family think I should do about colorectal cancer
screening.
.62Social influence
Members of my immediate family think I should have colorectal cancer screening.b
My doctor or health professional thinks I should have colorectal cancer screening.b
I want to do what my doctor or health professional thinks I should do about colorectal cancer
screening.
I am afraid of having an abnormal colorectal cancer screening test result..80Cancer worries
I am worried that colorectal cancer screening will show that I have colorectal cancer or polyps.
The chance that I might develop colorectal cancer is high..65Perceived susceptibility
Compared with other persons my age, I am at lower risk for colorectal cancer.c
It is very likely that I will develop colorectal cancer or polyps.
The chances that I will develop colorectal polyps are high.b
When colorectal polyps are found and removed, colorectal cancer can be prevented.b.59Response efficacy
When colorectal cancer is found early, it can be cured.
I think that doing the test would be easy for me.b.75Self-efficacy
Finding time to do the test would be difficult for me.c
Completing the test correctly would be easy for me.
Collecting feces for the purpose of bowel cancer screening is unhygienic.c.71Fecal aversion
Collecting feces for the purpose of bowel cancer screening is distasteful.b,c
Giving a sample of feces to another person is embarrassing.c
a Preventive Health Model (PHM) construct descriptions and survey items reproduced from [8].
b Statements used for tailored assessment.
c Items were reverse coded.
Tailored Content
The steps involved in the production and presentation of tailored
messages [22,25] are described subsequently.
Developing Tailoring Assessment Feedback Statements
Statements upon which tailored feedback would be based were
identified. To maximize message salience and minimize message
length, the item from each of the PHM factors that loaded most
highly on that factor provided the message utilized [7] because
previous research has established the cross-national validity of
the PHM [10]. A “cancer worries” statement was not included
because concern was addressed in statements derived for other
variables. The fecal aversion and self-efficacy tailored feedback
statements were chosen on the basis that they included aspects
of all aversion or self-efficacy statements. The form of message
feedback provided was determined by the strength of the rating
provided by the participant. The aim was to reinforce the person
when they provided feedback that was consistent with screening
participation and to motivate those respondents whose ratings
were inconsistent with screening participation. Progression of
such messages is illustrated in Table 3; a similar series of
messages was developed for each variable.
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Table 3. Creating a library of tailored messages for the Preventive Health Model (PHM) factor “response efficacy” presented in order from reinforcing
to motivating.
Response efficacyaFactor
When colorectal polyps are found and removed, colorectal cancer can be prevented.Tailoring statement
[Name], you’ve told us that colon cancer screening is effective. You’re absolutely right. That is why the Australian Cancer
Council recommends yearly screening for people over 50 who are of average risk. It’s an important step to take to protect your
health for the future, and could save your life.
Strongly agree (5)
[Name], you’ve told us that you believe colon cancer screening is effective. You’re right. That is why the Australian Cancer
Council recommends yearly screening for people over 50 who are of average risk. It’s an important step to take to protect your
health for the future, and could save your life.
Agree
[Name], you’re not sure that colon cancer screening is effective. It’s very effective—that’s why the Australian Cancer Council
recommends yearly screening for people over 50 who are of average risk. As you are [age], it’s an important step to take to
protect your health for the future, and could save your life.
Not sure
[Name], you don’t think that colon cancer screening is effective. In fact it’s very effective—that’s why the Australian Cancer
Council recommends yearly screening for people over 50 who are of average risk. As you are [age], screening could save your
life by finding early, curable cancer.
Disagree
[Name], you really don’t believe that colon cancer screening is effective. In fact it’s very effective—that’s why the Australian
Cancer Council recommends yearly screening for people over 50 who are of average risk. As you are [age], screening could
save your life by finding early, curable cancer.
Strongly disagree (1)
a Tailoring “fragments” shown in italics. Personalized fields indicated in square brackets.
Developing Tailoring Decision Rules
Decision rules were developed for each tailored feedback
variable based on “if-then-else” logic. Messages that addressed
PHM factors shown from previous research to be predictive of
moving people from their current decision stage to a “better”
stage [14] were given priority in the presentation of feedback
to individuals, to exploit the primacy effect [26]. The two factors
most strongly related to each decision stage (presented first to
those in that stage) are shown in Table 4.
Table 4. Relating Preventive Health Model (PHM) factors to Precaution Adoption Process Model (PAPM) decision stage for colorectal cancer screening
via fecal occult blood test (FOBT).
PHM factors most strongly associated with decision stageaPAPM decision stage
Salience and coherence, susceptibilityNever heard of FOBT
Susceptibility, response efficacyNot considered FOBT
Susceptibility, self-efficacyDecided against FOBT
Salience and coherence, self-efficacyUndecided about FOBT
Response efficacy, self-efficacyDecided to use FOBT
a Source: [14].
Preparation and Presentation of Tailored Messages
A combination of programming and manual steps ensured
correct presentation of messages. From the baseline survey data,
an access query obtained the participant’s name, age, scores on
each tailoring variable, and screening decision stage. This
information was manually entered into a logic program, a
“message concatenator” that accessed the message library and
produced a set of personalized reinforcing or motivating
messages according to scores. The messages were divided into
“chunk 1” (messages addressing the factors most salient to the
participant’s decision stage as seen in Table 4) and “chunk 2”
(messages addressing the remaining factors as seen in Table 2).
The text of both sets of messages varied by individual—those
at the same decision stage (having the same salient and less
salient factors relating to that decision stage) may have scored
those factors differently, so messages would reflect the
divergence in scores. An example of a completed concatenator
form and the resultant set of messages is shown in Figure 1.
As Figure 1 indicates, the underlying message–merge syntax
resulted in duplication of words and phrases, concepts running
together, and seemingly random placement of the personalized
name and age details. These messages were subsequently edited
by the first author in order to omit duplicated phrases and
enhance flow between PHM factor concepts. Following is an
example of a portion of the final edited message format.
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Figure 1. Message concatenator entry and resulting tailored message chunks.
Chunk 1 Text, Your Information (Part 1)
Greg, you believe that colon cancer screening is
effective. You’re absolutely right. That’s why the
Australian Cancer Council recommends yearly
screening for people over 50 who are of average risk.
It’s an important step to take to protect your health
for the future, and could save your life.
However, you’re not sure whether you’re at risk for
having or developing colon polyps or cancer. Well,
you are at risk. Colon polyps are common in people
over 50, and colon cancer is a common cancer in this
age group. You are 57, so your risk for these
conditions is increasing as you get older.
Chunk 2 Text, Your Information (Part 2)
You think that screening would be a difficult thing to
do, but it really isn’t. The FOBT kit is designed to be
easily used in the privacy of your home at your own
convenience, where you can take all the time you
need.
You do think colon cancer screening makes a lot of
sense. You’re right, Greg. People can have colon
polyps or cancer and not know it. Screening can find
any problems early and protect your health.
Once edited, for the Web-based/tailored group, messages were
entered into a program that displayed them on the computer
screen, matched to the participant for whom they were intended.
Messages bound for the paper-based/tailored group were copied
and pasted into the appropriate spot in the personalized materials
presented to each participant.
Generic Information and Educational Content
Generic information statements to encourage colorectal cancer
screening are shown in Textbox 1.
Educational material was provided to all groups as a component
of informed decision making [27]. Its content closely followed
the format of information presented in the NBCSP consumer
information booklet [28] and although it did not go into detail
about the risks of screening (false negatives that can lead to
people being wrongly assured and false positives that can result
in unnecessary anxiety and diagnostic procedures), the material
reproduced information that would be received by those targeted
in the Australian population-based screening program. An
indicative extract from the table of contents is shown in Textbox
2.
The paper group received the educational material in the form
of a series of pages arranged in typical paper-based fashion (ie,
with a table of contents and corresponding page numbers) and
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text that progressed according to the table of contents. The Web
group received the same material but as a series of headings,
tabs, and hyperlinks. Web pages were designed to reflect issues
of vision and cognition needs of older users; for example, the
ability for text to be enlarged, contrast to be changed, and use
of adequate white space [29]. A sample of the Web page is
shown in Figure 2.
Textbox 1. Generic Information Statements to Encourage Colorectal Cancer Screening.
Some important messages concerning screening for colorectal cancer:
• People can have colon polyps or cancer and not even know it. Colon polyps are common in people over 50, even in those with no family history.
Finding colon cancer early and removing colon polyps when they are small can prevent cancer.
• The risk for these conditions increases with age; that’s why regular screening from the age of 50 onwards is so important.
• Colon cancer screening is very effective—that’s why the Australian Cancer Council recommends yearly screening for people over 50 who are
of average risk.
• The medical profession recognizes that such screening is effective, and supports the Australian Cancer Council recommendation for yearly
screening.
• Colorectal cancer screening is easy to do. The kit is designed to be quickly and easily used in the privacy of your home at your own convenience.
• Some people may think that doing the test might be unhygienic or embarrassing, but this needn’t be so. Recognizing that there is nothing wrong
with testing feces for cancer and using the kit could save lives.
Textbox 2. Web- and Paper-Based Educational Content: Extract of Major Headings From the National Bowel Cancer Screening Program Consumer
Information Material [28].
About bowel cancer:
• What is bowel cancer?
• How common is bowel cancer?
• What causes bowel cancer?
• What are the symptoms of bowel cancer?
• Can bowel cancer be prevented?
• Who is at risk of bowel cancer?
Screening for bowel cancer:
• What is screening?
• What does the FOBT involve?
What happens if my result is positive?
• What does a colonoscopy involve?
• Are there any risks from a colonoscopy?
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Figure 2. Screenshot of Web-based educational content.
Screening Offer
An FOBT order form accompanied the print and Web material.
Participants had the option of completing the form immediately
after viewing the material and leaving the completed form with
the researchers (paper group) or using a hyperlink to email their
details (Web group). The screening kit included (1) a bowel
cancer screening information pamphlet; (2) an immunochemical
FOBT (InSure, Enterix Australia) that does not require dietary
or drug restrictions; (3) a combined participant details and
consent form confirming personal details, nominating a preferred
doctor for follow-up, and consent to obtain clinical follow-up
reports if required; and (4) a reply-paid return envelope
addressed to the processing laboratory. The processing
laboratory provided the researchers with de-identified FOBT
receipt information.
Data Analysis
Chi-square analyses (χ2) and one-way analyses of variances
(ANOVAs) were initially undertaken to confirm group
comparability at baseline. A mixed-group design ANOVA with
two between-group factors—message delivery modality (Web
or paper) and message type (tailored or non-tailored)—and one
within-subject factor, time of measurement (baseline–time 1
and endpoint–time 2), was undertaken to examine for main
effects from message, modality, and time of measurement, and
their interaction on the main outcome variables. These main
effects and interaction terms were examined in order to test
whether attitudes and beliefs, as reflected in scores on the PHM
variables and self-efficacy and fecal aversion, improved over
time, and were influenced by the message delivery modality
and the nature of the message. It was hypothesized that tailored
messages delivered via Web modality would be associated with
greatest improvement. The effect of modality and message type
on categorical outcome variables (ie, decision stage movement,
FOBT request, and uptake) was examined using Chi-square
analyses. Participation rates were defined as “early” or “late”
at a cut-off point of 6 weeks following dispatch of FOBT, and
“non-return” at a cut-off point of 12 weeks. All analyses were
conducted using a two-sided alpha level of .05.
Results
From a sampling frame of 756 people, 532 people were
contacted at baseline. Of these, 298/532 (56.0%) declined to
participate and 134/532 (25.2%) were ineligible. In total,
100/756 (13.2%) agreed to participate in the study. There was
no significant difference in gender distribution (the only
demographic variable obtained from non-participants) between
those who declined to participate and participants (χ21 = 0.2, P
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= .68). Because the numbers in the intervention groups were
lower than anticipated, we resorted to “snowball” [30]
recruitment (n = 19) to increase the number of participants to
within approximately equal numbers in each group.
“Snowballing” is a chain-referral method whereby a study
participant who fits the eligibility criteria uses their social
networks to recruit participants with similar characteristics.
Those participants then recruit others, resulting in a process
analogous to a snowball rolling down a hill. Subsequently, 15
participants (2 in the paper/non-tailored, 5 in the paper/tailored,
6 in the Web/non-tailored, and 2 in the Web/tailored groups)
did not attend the laboratory for the intervention. Therefore,
full data were available for 95.7% (104/119) of participants.
Although “snowball” recruits comprised 17.3% (18/104) of the
final sample and varied between groups, there were no
significant differences between groups for gender, mean age,
education, Australian birth, marital status, and awareness of
FOBT (Table 5).
















9 (45)8 (38)10 (50)10 (48)15 (68)Male
11 (55)13 (62)10 (50)11 (52)7 (32)Female
.388.53
(8)
Education level, n (%)
10 (50)7 (33.3)4 (20)7 (33.3)6 (27.3)Some high school
8 (40)7 (33.3)8 (40)6 (28.6)6 (27.3)Completed high
school/trade
2 (10)7 (33.3)8 (40)8 (38.1)10 (45.4)University
.137.01
(4)
Place of birth, n (%)
19 (95)18 (85.7)13 (65)15 (71.4)18 (81.8)Within Australia
1 (5)3 (14.3)7 (35)6 (28.6)4 (18.2)Outside Australia
.771.79
(4)
Relationship status, n (%)
15 (75)15 (71.4)17 (85)15 (71.4)18 (81.8)With partner
5 (25)6 (28.6)3 (15)6 (28.6)4 (18.2)Single
.682.32
(4)
Heard of FOBT, n (%)
13 (65)12 (57.1)10 (50)9 (42.9)11 (50)Never heard of
FOBT
7 (35)9 (42.9)10 (50)12 (57.1)11 (50%)Heard of FOBT
.560.75
(4.99)
62 (6.8)59 (7.9)60 (6.2)62 (6.4)61 (7.0)Age, mean (SD)
a Snowball (n = 1).
b Snowball (n = 6).
c Snowball (n = 6).
d Snowball (n = 5).
Change in PHM Scores
Initial examination of movement in attitudes and beliefs of the
control group across time were examined using related samples
t tests. No significant changes were observed, suggesting that
scores on PHM variables and fecal aversion and self-efficacy,
without intervention, were all stable and reliable across time.
Descriptive statistics for intervention groups according to
condition (ie, 2 × 2 × 2) are presented in Table 6, and the results
of the repeated measures ANOVAs are presented in Table 7.
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Overall, there was a significant change in scores pre- and
post-intervention for all variables. However, there were no
significant time × modality interactions, indicating no difference
between groups due to receiving paper versus Web-based
information. There were significant time × message interactions
for both perceived susceptibility and self-efficacy. Perceived
susceptibility scores for individuals receiving tailored
information increased from mean 10.6 (SD 2.1) to mean 11.8
(SD 2.2). Scores on self-efficacy increased in the tailored group
from mean 11.7 (SD 2.0) to mean 12.6 (SD 1.8). There were
significant time × modality × message effects for social
influence and salience and coherence, reflecting an increase in
these scores for tailored Web-based participants only: social
influence scores increased from mean 11.7 (SD 2.6) to mean
14.9 (SD 2.3) and salience and coherence scores increased from
mean 16.0 (SD 2.2) to mean 17.7 (SD 2.1).
Table 6. Means and standard deviations on all PHM, fecal aversion, and self-efficacy outcome variables according to condition.









17.7 (2.1)16.6 (2.3)16.0 (2.2)16.4 (2.5)TailoredSalience and coherence
16.1 (2.5)17.6 (1.8)15.8 (2.4)17.0 (2.3)Non-tailored
4.3 (2.1)5.9 (1.9)5.2 (2.1)6.3 (1.6)TailoredCancer worries
5.0 (1.9)4.4 (1.8)5.0 (1.9)4.5 (2.1)Non-tailored
12.3 (2.3)11.4 (2.1)10.8 (2.1)10.4 (2.1)TailoredPerceived Susceptibility
10.9 (2.1)11.0 (2.2)10.8 (2.3)10.9 (1.6)Non-tailored
8.1 (1.1)8.0 (1.2)7.7 (1.1)7.5 (1.1)TailoredResponse efficacy
8.2 (1.0)8.1 (1.3)7.7 (1.3)7.4 (1.0)Non-tailored
14.9 (2.3)14.5 (2.0)11.7 (2.6)13.5 (1.9)TailoredSocial influence
14.1 (2.9)14.9 (2.5)12.9 (2.6)12.7 (2.7)Non-tailored
13.0 (1.9)12.1 (1.6)11.7 (1.9)11.7 (2.2)TailoredSelf-efficacy
12.2 (1.5)12.4 (1.4)11.9 (1.4)12.5 (1.3)Non-tailored
11.4 (2.8)10.4 (2.6)10.4 (3.0)9.5 (2.5)TailoredFecal aversion
10.6 (2.7)11.9 (2.2)10.3 (2.1)11.2 (2.0)Non-tailored
Table 7. Repeated measures ANOVAs comparing pre- and post-intervention group scores.










< .00111.03.480.50.221.54< .00165.80Social influence
.450.58.034.74.083.21< .0018.62Self-efficacy
.520.42.261.27.700.15< .00116.60Fecal aversion
a Time effect refers to pre- and post-intervention scores.
b F test for statistical difference between > 2 groups.
Movement in PAPM Decision Stage
Movement in the PAPM decision stage from pre- to
post-intervention was measured for modality and message
separately, and included the control group (Figure 3, shown as
a percentage of group). A greater percentage of the control group
“moved” compared to intervention groups; however, they moved
from “unaware of the issue” to only “heard of the issue but
unconcerned.” Although a similar percentage of Web- or
paper-based participants moved to deciding to screen, a greater
percentage of those receiving tailored (vs non-tailored) messages
moved to deciding to screen. Post-intervention movement of
intervention groups was further dichotomized as “moved to
screen” versus “other movement type” and excluded those who
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had decided to screen pre- and post-intervention (n = 20). A
Chi-square (with Yates continuity correction) analysis indicated
no significant difference for either modality (χ21 = 0.2, P = .62)
or message (χ21 = 2.3, P = .13), indicating that Web or tailored
delivery was no more effective than paper or non-tailored
delivery in moving people toward a decision to screen.
Figure 3. Movement in decision stage post intervention.
FOBT Participation
Including the control group, FOBTs were requested by 58.7%
(61/104) of participants at the interview and by another 9
participants following the interview (overall request rate 67.3%,
70/104). Completed FOBTs were returned by 58.6% (41/70)
of participants over a period of 14.1 weeks (mean 4.9 weeks).
Of the kits returned, 65.9% (27/41) were received within 6
weeks (“early”). For the intervention groups, there was no
significant difference in modality (Web vs paper) or message
(tailored vs non-tailored) for FOBTs requested or returned
(Table 8).













Interviews were conducted with all intervention group
participants by IF and EH, in groups or alone according to
number of participants at each session. They discussed issues
relating to acceptability of the information, particularly the
tailored messages, and acceptability of the website.
Impact of Tailored Message
Respondents who received tailored information had a positive
impression overall. The tailored information was viewed as an
acceptable substitute for a one-on-one conversation:
It was really in response to the information I had
given, and, it wasn’t patronizing but it was really just
confirming...Yes, I think that approach is beneficial.
It drags you in; it’s like having a conversation. [male,
Web/tailored group]
The fact that the tailored information addressed an individual’s
specific responses was positively regarded:
I think it reinforced things for me...I’d made one
comment that I perhaps agreed or disagreed, but this
was actually telling me why it was different...So for
me it’s a more direct approach and I found that very
useful. [female, Web/tailored group]
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Although some participants did experience the receipt of tailored
information as somewhat confronting:
I sort of didn’t realize what I had said. Well, I think
probably I’ve thought about it since, and thought well
that was a stupid statement to make...it was just a bit
strange seeing things that I’d said. [female,
paper/tailored group]
Acceptability of the Website
The presentation of the Web tool was described as requiring
improvement:
I’d be looking for clear indication on the site that gave me very
quickly, very clearly without a lot of words, what I’ve gotta [sic]
look for and what I can do to find out. It was a bit long and a
bit wordy—trying to put too much information. You can do more
with pictures than you can do with words. [male,
Web/non-tailored group]
...it wasn’t very exciting. It was very boring...there
weren’t any pretty pictures, it was sort of, you
know—very basic. [female, Web/non-tailored group]
I think beige would be more exciting! [male,
Web/non-tailored group]
Impact of Educational Content
Some male participants were surprised to learn that CRC and
prostate cancer incidence rates are similar. This suggested some
men were more aware of prostate cancer screening and
considered themselves more at risk for prostate cancer than
CRC:
It rose [sic] my awareness. I’m now aware that that’s a test that
I should be looking for. And put it in the same bracket as
prostate cancer, whereas it was not even on my radar. [male,
paper/tailored group]
When I saw the graph and I saw prostrate [sic] cancer and I
saw bowel cancer and they were almost identical, can’t
remember the exact numbers, but they were almost identical in
terms of amount. [male, Web/tailored group]
Discussion
This exploratory study tested the relative efficacy of
Web-delivered, tailored messages about CRC screening and
FOBT use on beliefs about and attitudes toward screening in
comparison to paper-delivered tailored messages and
non-tailored messages delivered by both paper and Web. In
addition to changes in PHM variable scores, outcomes included
changes in decision stage for screening, FOBT requests, and
participation.
After the interventions, there was an improvement in PHM
variable scores for all groups except the control group, who
received no information. For the intervention groups, all mean
scores significantly moved in the desired direction (eg, decreased
cancer worries or increased support for cancer screening
identified in all other psychological variables). Although not
influencing every factor, receipt of tailored messages increased
perceived susceptibility and self-efficacy and increased both
salience and coherence and social influence when combined
with Web delivery. Perceived susceptibility has been shown to
be a predictor of intention to screen [31,32]. Similarly, a
person’s confidence in their capacity to act (self-efficacy) is
widely reported as a predictor of actual health behavior
participation [33] and has been shown to moderate the
relationship between intention, planning, and action [34,35].
Thus, it appears that messages tailored to individual levels of
these important factors have a greater likelihood of beneficially
influencing screening behavior than more generic messages.
Salience and coherence and social influence are also important
behavioral determinants of screening [8]; it is unclear how Web
delivery interacted with tailoring to improve these scores.
Overall, there was no indication of a modality effect for PHM
factors; the delivery channel alone (paper or Web) had no direct
influence on score changes. Web delivery enables a shift from
the use of static material to a dynamic interactive resource [36]
that could be expected to provide more sophisticated and
effective decision support. Qualitative data suggests that the
site may not have fulfilled expectations with regard to “media
richness.” “Rich” media are generally characterized by the
capacity for immediate feedback, the capacity to transmit
multiple cues, the use of language variety, and capacity of the
medium to have a personal focus [37,38]. The Web-based
educational content of the decision support tool was designed
to be comparable with the paper version, with only the presence
of hyperlinks differentiating the modes of transmission (Figure
2). Interview feedback suggested participants found the
information “boring” and “dry” in comparison to other websites
and this may have affected their level of engagement. This result
highlights the need to ensure that Web-based information is
presented in media-rich format that users have come to expect,
albeit with due consideration of the needs of the target age group
(eg, issues of cognition, readability, vision, and disability) [29].
Regarding movement in decision stage, more people in the
control group moved from “never heard of FOBT” to no further
than “not considering” FOBT. This result corresponds with the
control group’s lack of movement in PHM scores and clarifies
that the act of being asked to just think about the factors
associated with screening without accompanying more specific
information is unlikely to encourage screening uptake. Although
there was greater movement toward a decision to screen in the
intervention groups, no one modality or message type was more
effective than the other. The lack of effect of Web versus paper
delivery could be ascribed to the previously mentioned lack of
expected Web-based richness of information. However, receipt
of tailored messages, compared to non-tailored material, had a
beneficial effect on several PHM factors and could be expected
to increase intention to screen.
Despite a growing evidence base showing that tailored messages
are superior to generic messages in their ability to influence
health behavior [39], the mechanisms by which tailoring works
is still unclear [40]. Tailored feedback can take different
forms—descriptive, comparative, evaluative, or a combination
[25,41]—and their relative effectiveness may differ between
individuals. For example, some study participants found our
descriptive approach (providing feedback on what is known
about the recipient based upon their PHM responses) confronting
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(eg, it was a “...bit strange seeing things that I’d said”) and the
language may have lacked empathy. Message framing may also
have an influence. For example, Akl and colleagues [42] in their
systematic review noted that loss messages (vs gain messages)
led to more positive perception of effectiveness for screening
messages. Others have found that differing presentation of risk
factors (absolute vs comparative) had an impact on intention to
screen [43], and message order was found to influence responses
to breast cancer information [44]. Further research to test the
effects of different types of message feedback, framing, and
presentation order using both behavioral and communication
theories [45,46] in the CRC screening context would help
“unpack” the mechanisms through which tailoring has an
influence.
The FOBT request and uptake rates, although greater than the
control, were no different for modality or message type. Only
slightly more than half of the FOBTs requested were returned.
Although it is generally accepted that intention to screen is a
necessary precursor of action, other variables amenable to
tailoring may exert a greater influence on screening uptake. For
example, in a group of people committed to screening we found
that, in conjunction with self-efficacy, commitment explained
only 8.0% of variance [47], and others have found that life
difficulty variables were better predictors of action than intention
[48]. Other researchers have approached the choice of tailoring
variables in other ways (eg, by targeting the most important
barriers identified by participants themselves [49]).
We did not test whether knowledge of bowel cancer and
screening was enhanced through provision of the educational
material, or whether such knowledge helped participants decide
whether or not to screen. Knowledge is a critical component of
informed decision making; however, as Jepson and colleagues
[50] point out, a tension exists between the need of a screening
program to attain high rates of uptake and the promotion of
informed choice—an individual with whom information about
the explicit risks and benefits has been shared may choose not
to undertake screening (as in the case of prostate cancer
screening [51]). Although acknowledging the ethical imperative
of being able to make an informed choice, it is unclear whether
increased knowledge alone actually influences uptake. Increased
knowledge does not necessarily translate into action. This fact
has been demonstrated with respect to bowel cancer screening
[52,53], other screening behaviors [50,54-56], and organ
donation [57].
Regardless of the relative lack of effect of Web-based delivery,
from a practical perspective, using the Web as a delivery
medium for tailored information has significant advantages over
tailoring via paper. Material and decision rules can be created
and updated more easily and economically, thus maintaining
currency for a longer period, and the interaction required for
obtaining relevant information and providing tailored feedback
can occur in the one session. This creates a “real time”
interaction that can be linked to immediate behavior activation
(eg, ordering an FOBT online). Older people are increasingly
using the Internet. An earlier study we conducted found that
more than half the population over 50 years in South Australia
had access to the Internet at some location [58]. Others have
found that in South Australia the proportion of people aged 45
to over 65 years seeking Internet health information significantly
increased between 2001 and 2008 [59]. These data are likely to
be representative of greater Australia and other developed
countries.
Limitations and Strengths
There are some limitations with this study. First, our sample
was small, but it was consistent with that typically used in
exploratory studies. Second, those who did participate were
likely to have had greater focus on their health status and,
therefore, not necessarily representative of the external
population. Participants and non-participants did not differ in
gender, although we acknowledge that they may have differed
on other variables. It was not possible to measure the extent of
any potential bias without detailed information on those who
did not participate, which was inherently unavailable. We also
had a lower than expected initial uptake rate, necessitating
snowball recruitment and the associated loss of randomization.
Nevertheless, by means of this exploratory study we gained
sufficient indication of the beneficial effect of tailored material
on FOBT screening attitudes and participation to justify the
formulation of feasible hypotheses upon which to expand our
research. We also gained a participant perspective of the
usability and the content of the website. These results will be
incorporated into the design of a larger, truly randomized trial
using an improved Web interface. The process of producing
and presenting tailored messages from survey responses was
labor-intensive and not readily transferable to population
settings. Going through the process, however, highlighted the
potential for the development of more sophisticated, fully
automated message libraries and the use of natural language
generation systems, for example [60,61].
Despite that randomization was broken, strengths of the study
included the majority of participants (although self-selected)
were randomly sampled from a population frame, thereby
providing a stronger indication of generalizability of results.
We used behavioral constructs that had been validated as
predictors of CRC screening, and FOBT participation was not
measured by self-report alone.
Conclusions
This exploratory study has confirmed that the provision of
tailored messages that address attitudes and perceptions of
screening that are amenable to change are more likely to result
in increased readiness to screen for CRC compared to provision
of generic information alone. However, despite increased PHM
scores and generally positive qualitative feedback, tailored
messages did not result in significantly increased requests for
an FOBT or its actual use. Future research should address
optimal message framing and construction, and consideration
of other possible psychosocial influences on screening uptake.
Mode of delivery did not affect outcomes, but this may have
been due to Web design deficiencies. From a public health
promotion perspective, the Web has economic and logistical
advantages over paper as a delivery medium.
We are currently undertaking a large-scale, randomized
population trial using a redesigned Internet decision aid [62] to
construct and deliver tailored messages in real time. Based on
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the results of this exploratory study, we have been able to
improve the quality and precision of our intervention. We
ensured that the initial sample approached would be large
enough, after allowing for attrition through non-eligibility and
non-participation, to retain sufficient power to detect statistically
significant group differences for the primary outcomes. This
study also highlighted that the steps involved in gaining
responses to PHM variables upon which to base tailored
messages, and the process of preparing the messages for
presentation in a coherent manner, was labor-intensive and not
compatible with a population-based screening program.
Therefore, in the larger trial [62], baseline survey responses will
be collected in real time and participants in the tailored
information group will receive immediate tailored feedback.
Additionally, an automated tailored message library using
sophisticated algorithms [61] will be used to ensure that
messages are united with natural language so that they can be
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